Medicine + Health, Fall 2011 by George Washington University, School of Medicine and Health Sciences, Office of Communications and Marketing
NON-PROFIT ORG.
U.S. POSTAGE
PAID
MERRIFIELD, VA
PERMIT NO. 593
FALL 2011
The GeorGe WashinGTon UniversiTy school of Medicine and healTh sciences
A CleAr PAth to 
the heArt 
Cardiac Interventionalist  
Ramesh Mazhari, M.D.
A CleAr PAth to 
the heArt 
CardiaC interventionalist 
ramesh mazhari, m.d.
A NOTE FROM ROSS HALL  
his column is the fi rst in my current role 
as interim vice provost for health affairs 
and dean of GW’s School of Medicine and 
Health Sciences (SMHS). I was appointed in De-
cember 2010 as the Medical Center embarked on 
a complex reorganization. In addition to those ad-
ministrative changes, this has truly been a remark-
able year for SMHS in terms of its faculty recruit-
ments, its medical student and residency matches, 
its research productivity, and the enhanced stature 
of its academic programs.
This also was a year, however, in which two 
GW doctors, important to me in very different 
ways, passed away. One of these physicians, 
Herbert Weintraub, M.D., was well known to 
our SMHS family. The other physician, Leonard 
C. Akman, M.D., was best known by his fellow 
members of the Class of 1943. 
Herb Weintraub was a highly esteemed former 
chair of GW’s Department of Anesthesiology. 
Although I knew him only in his post-retirement 
years, he was part of the generation of nation-
ally recognized academic physicians who came to 
GW in the 1970s and built the modern academic 
medical center that we know today.
This group included many of Herb’s colleagues: 
Burt Epstein (anesthesiology), Allan Weingold 
(OB/GYN), Sy Perlin (psychiatry), and many 
others who trained thousands of GW residents, 
medical students, and health science students. 
They also educated and trained many of the cur-
rent and former leaders at SMHS, including me. I 
am profoundly grateful to Herb and the other fac-
ulty who led the Medical Center for three decades. 
A few days before I left to begin medical school 
at GW, my father’s cousin, Leonard Akman, 
dropped by my family’s home for a visit. Leonard, 
an SMHS alumnus, was a very private man and a 
highly regarded cardiologist. So it was a great sur-
prise when he gave me a beautiful new microscope. 
Today, medical students learn microscopic 
anatomy sitting in front of a computer screen. In 
1977, however, we brought our own microscopes 
to learn histology, microbiology, and pathology. 
That gift was a demonstration of Leonard’s pro-
found, quiet connection to GW.
Through the years, GW colleagues would ask 
me about Leonard. He remained private, however, 
and while his relationship with my family blos-
somed, he still had little contact with his class-
mates. But, thanks to my encouragement, Leonard 
returned to GW in 1993 to celebrate his 50th M.D. 
class reunion. It was a joyous occasion for him and 
gave me further understanding of the crucial role 
that GW played in his life.
I doubt that Herb Weintraub and Leonard 
Akman knew each other. Yet both their lives 
were profoundly infl uenced by their association 
with GW, and both showed their gratitude with 
generous bequests to the school. Herb’s gift will 
support residency training in the Department of 
Anesthesiology. Leonard’s gift will support educa-
tion and scholarships in the name of his parents.
My leadership role at SMHS is infl uenced by 
Herb Weintraub and his generation of physicians, 
and by Leonard Akman’s love of his alma mater.
 
Sincerely,
JeFFreY s. aKman, m.d. ’81, G.m.e. ’85
INTERIM VICE PROVOST FOR HEALTH AFFAIRS
AND DEAN, SCHOOL OF MEDICINE AND HEALTH 
SCIENCES
Affi rming a Profound 
Association with GW
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From THE CENTEr
Neurology Welcomes 
New Chair Kaminski
Following an extensive national 
search, GW’s School of Medicine and 
Health Sciences (SMHS) has selected 
Henry J. Kaminski, M.D., as the Meta 
Amalia Neumann Professor and Chair 
of the Department of Neurology. 
Kaminski most recently served as 
professor and chair of the Department 
of Neurology and Psychiatry and 
director of the Clinical Research 
Unit at Saint Louis University, and 
officially joined the GW faculty on 
Sept. 1, 2011.
“Dr. Kaminski is an internation-
ally recognized expert in care of 
patients with myasthenia gravis, and 
his research has received continuous 
sponsorship by the National Institutes 
of Health since 1993,” said Jeffrey S. 
Akman, M.D. ’81, G.M.E. ’85, interim 
vice provost for Health Affairs and 
dean of SMHS. “I have every confi-
dence that he will bring strong leader-
ship to the department.”
Kaminski’s studies are focused on 
understanding the biology of the extra-
ocular muscle and the pathogenesis 
of myasthenia gravis. His laboratory is 
currently working to develop inhibitor-
based treatments for myasthenia gravis 
and other neuromuscular disorders. 
Kaminski replaced John J. Kelly, 
M.D., who had served as professor 
and chair of the department with dis-
tinction for the last 20 years. n
White Coat Event Signals  
the Start of Something Big
More than 180 students were welcomed into the GW medical community at the 
annual White Coat and Honor Code Ceremony in Lisner Auditorium Aug. 20. 
Students received their first white medical coats, signifying the start of their 
journey toward careers in the medical profession. They also recited the GW 
School of Medicine and Health Sciences (SMHS) Oath and signed the GW 
Honor Code pledge.
GW’s class of 2015 — the most competitive in the history of SMHS — repre-
sents 29 states, the District of Columbia, and Canada. Among its ranks are 23 
emergency medical technicians, a professional lacrosse player, and a Fulbright 
Award winner.
Edward O’Neil Jr., M.D. ’87, associate professor of emergency medicine at 
Tufts University, gave the keynote address. 
O’Neil — who founded Omni Med, a Massachusetts-based nonprofit that 
trains health providers and community workers and runs health service pro-
grams in Uganda, Belize, Guyana, and Kenya — described the “sense of 
wonder” he felt during his first days as a physician and his health care work in 
some of the poorest regions in the world. He told the first-year medical students 
that physicians get to “perform miracles.
“As you start on this wonderful career of becoming physicians, I would ask 
that you find a passion to make a difference somewhere in your lives,” he said, 
adding, “engage in the problems of the world, because they are many.”
The annual event is sponsored by the GW Medical Alumni Association and 
the White Coat Initiative, who generously donate the funds to purchase each 
new class’s white coats. This year’s celebration was co-chaired by second-year 
medical students Todd Spock, DiAnne Davis, and Sarah Todd. n
Henry J. Kaminski, M.D.
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A Prescription for Change
The thought first struck what Vinayak Jha, M.D., assistant 
professor of Medicine, calls his “ridiculous nerve.”
Then, it struck his curiosity nerve, which struck his ac-
tion nerve. Suddenly, Jha — a pulmonary disease specialist 
and amateur community organizer — became committed to 
a cause that, just minutes earlier, he hadn’t known existed.
“When I learned that the sale of tobacco had been 
banned in pharmacies in San Francisco and Boston, I 
wondered what the status was in D.C.,” he recalls. “It didn’t 
take long to figure out that there is no status in Wash-
ington, D.C. In fact, hardly anyone had even heard of the 
issue.” And so he decided it was a cause worth fighting for.
TobaccoFreeRx, Jha’s resulting campaign, seeks to 
eliminate the sale of tobacco in Washington, D.C., phar-
macies (including retail stores that contain pharmacies) 
through a combination of grassroots advocacy, endorse-
ments from professional and government organizations, 
and tactics of “embarrassment and exposé,” he admits.
“What characterizes a place that calls itself a pharmacy 
is having a health care provider who is licensed by the 
Department of Health, whose sworn goal — and personal 
philosophy — is to keep people healthy,” Jha reasons. 
“Unlike a convenience store or gas station, these places 
are operating as health care enterprises, so they shouldn’t 
sell the same products that will cause the diseases for 
which you need the medications.”
Since the launch of TobaccoFreeRx, Jha has emerged 
as an accessible resource for other activists across 
the country. He has helped an Oregon county health 
department pass an ordinance prohibiting tobacco sales 
in pharmacies and an anonymous pharmacist write a 
tobacco-free policy for a pharmacy chain. 
Locally, Jha has presented his case to the D.C. Board  
of Pharmacy and initiated discussions with the D.C. 
Department of Health and the dean of the Howard University 
School of Pharmacy.
Jha says that legislation is not the only route to suc-
cess. Most importantly, he hopes his efforts will strike 
other people’s ridiculous nerves. “I hope this is just a 
moment in time,” he says, “and maybe 10 or 20 years from 
now we’ll look back and say, ‘Boy, isn’t it ridiculous that 
pharmacies were still selling cigarettes in 2011?’ ” n
Avon Foundation Supports Patient  
Navigation, Breast Cancer Tests
The George Washington University Cancer Institute (GWCI) 
and the School of Medicine and Health Sciences (SMHS) 
received a pair of grants from the Avon Foundation totaling 
$400,000 to support patient navigation services and 
research to develop a new test to assess risk of breast 
cancer. Christina Cianflone, director of GWCI’s Division 
of Cancer Prevention and Community Health, accepted 
a check on May 1, during the closing ceremony for the 
Washington, D.C., Avon Walk for Breast Cancer.
“The support of the Avon Foundation allows us to 
continue to provide access to screenings and follow-up 
care for women in the most vulnerable populations and 
expand our patient navigation services in the GW Breast 
Imaging Center,” said Cianflone.
GWCI received a $250,000 award to support three 
patient navigation and education programs — a 
partnership with the Capital Breast Care Center to help 
underserved women receive screening and follow-up 
care; patient navigation services offered by the GW Breast 
Imaging and Intervention Center, and GWCI’s m-health 
Breast Self-Exam Reminder Text Message Program. 
For the third consecutive year, SMHS received a 
$150,000 Avon grant to support research led by Patricia 
Berg, Ph.D., professor of Biochemistry and Molecular 
Biology. The project seeks to develop a new test to assess 
risk of breast cancer. n
From THE CENTEr
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From the CeNter
Schistosome Parasites Linked  
to Deadly Bladder Cancer 
Researchers at GW’s School of Medicine and Health Sciences (SMHS) have 
identified a gene that enables the parasite Schistosoma haematobium to es-
tablish a foothold in its human host, which ultimately may lead to a devastating 
form of bladder cancer. 
Schistosomes, or helminth worms, are waterborne parasites that can cause 
chronic inflammation and fibrosis in the liver, symptoms that may migrate to the 
bladder, causing inflammation, granulomas, and eventually, bladder cancer. The 
worm is responsible for two-thirds of the world’s 200 million to 400 million cases 
of human schistosomiasis, resulting in an estimated 280,000 deaths per year.
In the July issue of the journal Hepatology, researchers from SMHS describe 
how they demonstrated the role of the metastasis-associated protein-1 (MTA1) 
gene in the proliferation of schistosomes. They infected two strains of mice with 
schistosome cercariae, a larval stage of the parasite. One group of mice, wild-
type, had an intact MTA1 gene in their DNA. The other mice, MTA1-/-, lacked 
that gene, but were otherwise genetically normal. MTA1 is a crucial gene that 
controls the process of chromatin remodeling of cytokines, including those 
responsible for inflammation. By using the mice that lacked the gene, inves-
tigators were able to compare their 
reaction to parasite infestation to that 
of the normal, wild-type mice. 
At various stages after infection, 
blood from the portal circulatory 
system of the liver was analyzed for 
worms and parasite eggs. “At the 
12th week of infection, we found that 
the wild-type mice had severe granu-
lomatous lesions in the liver,” says 
lead author Sujit Nair, Ph.D., assistant 
research professor in SMHS’s Depart-
ment of Biochemistry and Molecular 
Biology. “Their worm count was very 
high. In the mice that did not have 
the gene, however, there were neither 
worms nor eggs that we could collect 
from the portal perfusion.”
From these results, the researchers 
concluded that absence of the MTA1 
gene does not compromise the mice’s 
susceptibility to the parasite infection, 
but it does limit the survival or matura-
tion of schistosomes in the host, and 
possibly egg release and deposition.
Senior author Rakesh Kumar, 
Ph.D., professor and Catharine 
Birch & William McCormick Chair of 
Biochemistry and Molecular Biology, 
explains that expression of MTA1, 
a nuclear protein, regulates the 
expression of inflammatory cytokines 
that are produced by Th1 and Th2 
cells of the immune response. By 
increasing the expression of MTA1 
in the wild-type mice, the parasite 
“hijacks” the gene, “which in 
turn allows it to up-regulate pro-
inflammatory cytokines, and these 
pro-inflammatory cytokines in turn 
will provide a favorable atmosphere 
for the pathogens to grow and cause 
a persistent inflammation,” he says. 
“It’s the persistent inflammation 
over time that we believe can lead to 
cancer.” n
Schistosome Cercariae
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From the CeNter
Sudden cardiac arrest (SCA) is the nation’s leading cause 
of death, claiming more lives each year than breast cancer, 
lung cancer, and HIV/AIDS combined. Starting with an 
electrical disruption in the heart’s normal rhythm, SCA leaves 
victims with weak, fluttering heartbeats. Blood stops flowing 
properly, depriving the body of precious oxygen. Brain 
injury will ensue unless blood flow is restored within five 
minutes. According to the American Heart Association, for 
each minute of delay before normal blood flow is restored, 
the likelihood of survival decreases by 10 percent. Overall, 
survival rates for SCA range from a high of 16.3 percent to a 
low of 3 percent in some regions of the country.
District of Columbia Public Library System patrons and 
employees now stand a better chance of beating those 
odds, thanks to The George Washington University Cheney 
Cardiovascular Institute’s “ReStart DC” program, which 
donated automated external defibrillators (AEDs) to all 
25 library locations. The AEDs, presented in May at the 
library system’s Chevy Chase branch, marked the 100th 
community donation since the ReStart DC AED program 
was launched in 2009. 
The Cheney institute launched the program with the 
goal of increasing survival rates from SCA in the District 
of Columbia. So far, it has donated AEDs to nonprofit 
organizations, community centers, houses of worship, 
and other organizations. ReStart DC also provides AED 
training, medical oversight, and direction for organizations 
serving low-income communities throughout the city. 
Now commonplace in public settings, such as airports, 
shopping malls, schools, and office buildings, the easy-
to-use devices are safe to operate and proven to save lives 
when seconds count the most. 
“As great as our cardiac program is, patients often 
reach us too late,” says Jonathan Reiner, M.D., professor of 
Medicine and director of The George Washington University 
Hospital’s Cardiac Catheterization lab. “By deploying AEDs 
and training people in CPR, we are enlisting the entire 
community to help in our efforts to improve survival rates 
by speeding the response to cardiac emergencies.”
AED donations to the DC Public Library system were 
made possible through the efforts of volunteers with the 
Friends of the DC Library and Mended Hearts, which 
raised a portion of the funding, as well as support from 
Philips Healthcare. n
GW Cheney Institute Donates  
100th Life-Saving Automated  
 External Defibrillator
Eliminating Breast  
Cancer Disparities 
Debbie Wasserman Schultz is often told that she is lucky 
to be alive. The 45-year-old congresswoman from Florida 
and the new chair of the Democratic National Committee 
overcame a particularly lethal type of breast cancer, but 
she says her survival has more to do with awareness and 
education than luck. 
As the keynote speaker at the “Eliminating Breast 
Cancer Health Disparities: Communicating to At-Risk 
Populations” symposium, Wasserman Schultz used her 
story to underscore the importance of both knowledge 
and access to care in the fight against breast cancer 
— a disease whose prevalence and severity varies with 
ethnic background. The event, hosted by GW’s School 
of Medicine and Health Sciences, the GW Medical Fac-
ulty Associates, the Avon Foundation for Women, and 
Friends of Cancer Research, explored how cancer cen-
ters, community health centers, advocacy organizations, 
and government agencies can improve communication 
with underserved populations in order to eliminate breast 
cancer disparities. 
The symposium featured a panel of local and national 
breast cancer advocates led by Rachel Brem, M.D., 
director of GW’s Breast Imaging and Intervention Center, 
who emphasized that a multifaceted solution is needed 
to address breast cancer disparities that arise from both 
biological differences and societal barriers to care. Sug-
gestions included boosting minority enrollment in clinical 
trials and increasing the use of patient navigators. 
“If there is one message here, it’s that there are multiple 
messages,” concluded Brem. “We have to work collabora-
tively with research, with education, with community health 
services in order to really optimize the care for all women.” n
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NCI-NIH Award Helps Researchers  
Battle Parasite-Induced Cancer 
Researchers from GW’s School of Medicine and Health 
Sciences (SMHS) received a $2.5-million grant from the 
National Cancer Institute of the National Institutes of Health 
to develop a technique for detecting a deadly form of bile 
duct cancer caused by parasites. The R01 award supports 
a team of SMHS researchers developing proteomic bio-
markers for Cholangiocarcinoma (CCA), a cancer caused 
by the liver fluke Opisthorchis viverrini. The foodborne 
parasite currently infects more than 40 million people, pri-
marily in the Southeast Asian countries of Thailand, Laos, 
and Cambodia, where fish infested with the parasite are a 
staple of the local diet. 
“CCA is a serious cancer with a very poor prognosis,” 
says Paul Brindley, Ph.D., a tropical disease specialist and 
professor in SMHS’s Department of Microbiology, Immu-
nology, and Tropical Medicine (MITM). Because patients 
often have nonspecific symptoms, such as abdominal pain 
and fatigue, the cancer “is usually not diagnosed until it’s 
well advanced, and sadly, people generally don’t live very 
long after it’s diagnosed,” he adds. 
The GW research team, led by Brindley and Jeffrey M. 
Bethony, Ph.D., associate professor in MITM, will use a 
quantitative proteomics approach to scan tumor tissues 
and matched plasma from bile duct cancer patients to 
From the CeNter
New Guidelines for Thyroid Disease 
During Pregnancy and Postpartum
An American Thyroid Association (ATA) task force led by 
Alex Stagnaro-Green, M.D., senior associate dean for 
Education and professor of Medicine and of Obstetrics 
and Gynecology at the GW School of Medicine and Health 
Sciences (SMHS), recently announced new guidelines for 
the diagnosis and management of thyroid disease during 
pregnancy and the postpartum period. The guidelines, 
published in the July edition of the journal Thyroid (v. 21, 
n. 10), are the culmination of nearly two years of compre-
hensive analysis of current practice, academic literature, 
and emerging research into the treatment of thyroid dis-
ease and its effects on pregnancy and postpartum. 
During pregnancy, the thyroid — an endocrine gland 
that regulates metabolism and influences critical body 
functions such as heart rate — produces up to 50 per-
cent more hormones than normal. “In essence,” explains 
Stagnaro-Green in the task force report, “pregnancy is a 
stress test for the thyroid, resulting in hypothyroidism in 
women with limited thyroidal reserve or iodine deficiency.”
Over the years, a growing body of research — much 
of which has been conducted by Stagnaro-Green him-
self — has indicated that even slightly too much or too 
little thyroid function during pregnancy can raise the 
risk of spontaneous miscarriage, preterm delivery, and a 
decreased IQ in the unborn child. But until now, this and 
other related research has not been translated into guide-
lines for clinical practice. 
Stagnaro-Green’s international team of experts 
included thyroidologists, obstetricians, and midwives in 
order to develop guidelines that would be comprehen-
sive and widely adoptable. Together, they developed 73 
recommendations in nine areas, which are thyroid function 
tests, hypothyroidism, thyrotoxicosis, iodine, anti-thyroid 
antibodies and miscarriage/preterm delivery, thyroid nod-
ules and cancer, postpartum thyroiditis, screening during 
pregnancy, and areas for future research. 
Each guideline was reviewed on the basis of the varying 
levels of conclusive evidence; thus, the task force rated the 
strength of each according to the United States Preven-
tive Services Task Force Guidelines. Of the 73, only 18 
received the highest recommendation level — an indication 
that there is still much to learn about the role of the thyroid 
during pregnancy and the postpartum period.  
“It is our hope that the present guidelines provide useful 
information to clinicians and help achieve our ultimate goal 
of the highest quality clinical care for pregnant women and 
their unborn children,” Stagnaro-Green concluded. n
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From the CeNter
identify potential biomarkers near the 
disease site. The researchers will then 
verify these markers by examining 
plasma from members of the study 
who are at risk for the cancer but are 
currently healthy. 
The GW team will partner with 
Jason Mulvenna and Alexander 
Loukas from the Queensland Tropical 
Health Alliance, James Cook Univer-
sity, in Cairns, Australia, and Banchob 
Sripa, head of the Tropical Disease 
Research Laboratory, Department 
of Pathology, Faculty of Medicine 
at Khon Kaen University. Although 
parasite-induced cancer is a serious 
problem throughout Southeast Asia 
and southern China, its epicenter is 
near Khon Kaen University in north-
eastern Thailand. 
Brindley and Bethony began the 
CCA cohort study as part of an Inter-
national Collaborations in Infectious 
Diseases Research grant awarded by 
the National Institute of Allergy and 
Infectious Diseases. Researchers 
recruited residents from the endemic 
areas along the Chi River basin in 
northeastern Thailand, and they are 
currently following more than 1,000 
individuals identified to be at high risk 
of developing liver fluke-induced bile 
duct cancer. n
CCA is a serious cancer with  
a very poor prognosis 
because patients often have  
nonspecific symptoms and 
the cancer is usually not 
diagnosed until it’s well 
advanced . . .
Circulating in the fluid surrounding the brain is a little-known protein that,  
researchers have discovered, plays a crucial role in the growth and position  
of cells in the developing cortex. The discovery, made by a multi-institutional re-
search team at Children’s Hospital Boston led by Maria Lehtinen, Mauro  
Zappaterra, and Christopher Walsh and researchers from GW’s School of Medi-
cine and Health Sciences (SMHS), was published in the March 10 edition of the 
journal Neuron.
“This study is a game changer,” says Anthony-Samuel LaMantia, Ph.D.,  
director of the GW Institute for Neuroscience at SMHS, and an author of the 
paper along with Thomas Maynard, Ph.D., associate professor of Pharmacology 
and Physiology at GW. “It’s remarkable that signals are coming from the cere-
brospinal fluid — it makes sense, but no one really thought about it in this way.”
The cerebrospinal fluid was originally thought to be simply a colorless salt 
solution that served to cushion the brain and help maintain ionic balance,  
but when scientists looked more closely at it, they discovered something 
unexpected. The fluid contained high levels of a particular protein that signals 
brain cells to multiply at a critical moment in embryonic brain development. 
Researchers identified an insulin-like protein (Igf2) in the cerebrospinal fluid  
of mouse embryos that is known to prompt stem cells to multiply and differ-
entiate. When the researchers blocked Igf2, stem cells in the brain stopped 
making brain cells, and when the team placed brain stem cells in a dish filled 
with Igf2-rich cerebrospinal fluid, the cells proliferated rapidly. “This was clearly 
the environment the stem cells needed to be happy,” LaMantia explains.
Brain cells in the cortex — the outermost layer of the brain responsible for 
cognition, learning, and memory — multiply and move to their appropriate  
position between the second and third trimesters of development. But until 
now, researchers have had little luck finding the molecular signals that direct 
the process.
Brain cell proliferation, however, is a good thing only when the time is right. 
Unrestrained growth leads to tumors. According to this report, Igf2 knows when 
to activate thanks to proteins in the long glial cells that stretch from the inner 
part of the brain to its outer layer. These cells form early in development, and 
serve to guide younger brain cells on the way to their appropriate positions 
during development. 
If one of the steps in this pathway goes awry, Igf2 could be activated at the 
wrong time, causing uncontrolled proliferation. Indeed, brain cancer patients 
who have the worst prognoses appear to have the highest levels of Igf2. 
The fact that vital signals are sent from cerebrospinal fluid, however, could 
be good news for patients suffering from brain cancer. “It’s difficult to deliver a 
drug that will influence a specific spot within the brain tissue,” says LaMantia. 
Instead, clinicians might one day infuse brain fluid with medicine — possibly 
one that blocks the signals from Igf2 telling cells to proliferate. “The possibili-
ties for using the fluid as an efficient mechanism to deliver small molecule 
drugs are endless,” he says. n
Stem Cells Take Cues  
from Fluid in the Brain
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A Legacy of Excellence
Anton SidAwy, M.d., M.P.H., SHAreS HiS ViSion for 
tHe future of Surgery At gw
hen Brian Blades, M.D., was appointed 
chair of Surgery in 1946, there was no way 
he could have imagined what his depart-
ment would look like today. If he saw it 
now, he might compare the hospital’s 
computer-controlled robots — which frequently replace tra-
ditional scalpels — to visions possible only in science fiction 
novels. Surgeons, he might marvel, are no longer limited by 
the flexibility of their wrists or the acuity of their vision as 
they perform complex procedures. 
Blades couldn’t know what the future would hold, but he 
did have a vision: One that built a foundation that made all of 
today’s accomplishments possible, says Anton Sidawy, M.D., 
M.P.H. ’99, who began his tenure as chair of the department 
in December 2010. 
Now, Sidawy, an internationally renowned vascular 
surgeon, former chief of surgical services at the D.C. Veterans 
Affairs Medical Center, immediate past president of the 
Society for Vascular Surgery, and current editor-in-chief of 
the Journal of Vascular Surgery, has his own vision: “to take 
what is excellent and improve upon it.” 
Sidawy, who has served on the GW faculty for 25 years, 
aims to expand and reorganize the department, adding sur-
gical services, programs, and divisions, as well as a greater 
number of specialized subspecialties. “When you come to 
GW as a patient,” he explains, “not only will you be treated 
by a specialist, but you will be treated by a specialist with a 
very specific interest in your condition.” 
He has started the process by expanding a division he 
knows much about: vascular surgery, which was formerly 
a two-person operation. Sidawy added four surgeons to the 
team with a diverse set of interests, dramatically expanding 
the division’s clinical clout and workload. “In a short time, 
it has become one of the most comprehensive groups in the 
region,” he notes. Most of the new faculty members also 
will be conducting research and boosting the department’s 
capacity for clinical studies and trials. 
In addition, the Division of General Surgery will be 
restructured to promote the growth of subspecialties, including 
hepato-biliary-pancreatic surgery, bariatric surgery, minimally 
invasive surgery, foregut surgery, and trauma. Currently, a 
national search is under way for a new director of trauma. 
When the position is filled, Sidawy will have increased the 
department’s full-time faculty by about 25 percent. 
“It’s all really exciting. We are bringing in surgeons who 
not only are clinically top-notch, but also have research poten-
tial and are excellent educators,” he says. 
Sidawy also hopes to build upon the department’s edu-
cational endeavors, and recently founded the Division of 
Surgical Education, which will incorporate faculty from all 
specialties to study and develop new educational paradigms 
for students and residents.
Meanwhile, Sidawy remains cognizant of the depart-
ment’s storied past. He recently renamed the resident teams 
(formerly merely numbers) after Blades and other former 
chairs, including Paul Adkins, M.D., a renowned thoracic 
surgeon; Ralph DePalma, M.D., who strengthened GW’ sur-
gical residents’ research efforts; and Joseph Giordano, M.D., 
the founder of the GW Trauma Center. “This reminds resi-
dents and students of the excellent history the department has 
had over the years, and provides them and the junior faculty 
with a sense of continuity and historical perspective they can 
be proud of,” he explains. 
And Sidawy feels the same way about his new post. “On a 
daily basis, I work with surgeons who want to do the best they 
can do for patient care, education, and advancing the science of 
surgery,” he says. “I feel quite fortunate and proud to be given 
the opportunity to lead this department at GW, and to work 
with an excellent group of surgeons at this stage of my career.” n
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Hair Loss remedy 
Linked to Loss of Libido
ASSiStAnt ProfeSSor MicHAel S. irwig, M.d.,  
uncoVerS SeriouS ProbleMS witH ProPeciA
ccording to the American Academy of Derma-
tology, roughly 50 million men and as many as 
30 million women in the United States experi-
ence some form of hereditary hair loss. And 
by most accounts, Americans spend more than 
$1 billion each year on shampoos, potions, pills, toupees, and 
transplants to ward off the effects of hair loss. But how much 
is too much to pay for a full head of hair?
A new study by Michael S. Irwig, M.D., and assistant pro-
fessor of Medicine in the Division of Endocrinology at GW’s 
School of Medicine and Health Sciences, who is also director 
of the Center for Andrology, suggests that men who take the 
hair loss drug finasteride — marketed by Merck under the 
trademark Propecia — may be paying a much steeper price 
than they expected. In the study, published in the Journal of 
Sexual Medicine, Irwig reveals that otherwise healthy men 
taking finasteride may experience ongoing sexual side effects 
well after they stop using the medication. 
That news has attracted global attention; Irwig and his 
study have been widely featured in print, broadcast, and 
online media, including MSNBC.com, Time.com, and la 
Folha, one of Brazil’s largest newspapers. The story was fea-
tured on CBS television stations in Chicago, New York, and 
Philadelphia, as well as on CBS Radio.
Finasteride inhibits the enzyme that converts testosterone 
to dihydrotestosterone, the male hormone associated with 
virilization and male pattern baldness. The drug was initially 
approved by the U.S. Food and Drug Administration (FDA) 
in 1992, under the brand name Proscar, as treatment for an 
enlarged prostate. Five years later, the FDA approved finaste-
ride under the name Propecia to treat male pattern baldness. 
An endocrinologist by training, Irwig launched the study 
after seeing several patients who reported persistent sexual 
side effects despite having stopped taking finasteride. He 
then found a website featuring posts about persistent sexual 
and other problems that adversely affect quality of life, with 
entries from more than 1,400 men.
Irwig studied a pool of 71 healthy men ages 21 to 46, who 
did not report any psychological issues such as anxiety or 
depression before starting finasteride. A staggering 94 percent 
of the men said they developed low sexual desire, 92 percent 
said they developed decreased arousal, 92 percent reported 
developing erectile dysfunction, and 69 percent said they devel-
oped problems with orgasm. Most patients used finasteride for 
an average of 28 months, but sexual side effects lasted for an 
average of 40 months after use was discontinued. 
In the study, said Irwig, “we sought to characterize the 
types and duration of persistent sexual side effects in oth-
erwise healthy men who took finasteride.” He added that 
prior to his research, nobody had really described this effect. 
“While finasteride has been associated with reversible adverse 
sexual side effects in multiple randomized placebo-controlled 
trials, this is the first series to find that symptoms persisted 
for at least three months despite stopping finasteride.”
Although all the patients experienced the side effects for 
at least three months after they stopped using finasteride, 
explained Irwig, “as many as 20 percent said problems per-
sisted for up to five years.” 
The exact incidence of persistent sexual dysfunction is 
unknown, according to Irwig, because there is no accurate 
count of the number of people who have been prescribed 
the drug. He recommends that men contemplating the use 
of finasteride, whether for baldness or an enlarged prostate, 
discuss the potential risk for persistent sexual side effects 
with their doctors.
“Many of the men said, ‘Had I known about this before-
hand I might have chosen another option,’ ” said Irwig. 
“It underscores how important it is for physicians who are 
treating male pattern hair loss to discuss the potential risk of 
persistent sexual side effects with their patients.” n
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Although the surge of mobile technologies is 
good news for telecommunications compa-
nies, it’s even better news for those in need 
of health care when access is a problem. 
Through m-health, or the rapidly evolving 
practice of medicine and public health via 
mobile communications devices, the face of 
patient care is changing as studies and pilot 
programs test the efficacy of the handheld 
devices for use in medicine. 
Members of GW’s School of Medicine 
and Health Sciences (SMHS) are leading the 
way in these endeavors, exploring m-health 
technology for use in a variety of areas 
including critical cardiac diagnoses, medica-
tion adherence, and diabetes management.
The world is growing smaller as the cost of mobile technology plummets and 
more high-powered smartphones reach the hands of eager new customers. 
Many observers expect global mobile communications penetration to reach 
100 percent within the next five years, and by 2016 there will hardly be a spot 
on the planet where one can’t place a call using a cell phone.
Practicing Smarter with m-health Technology
By Thomas Kohout | Photography by Holger Thoss
Brian Choi, M.D., assistant professor of Medicine in the Division of Cardiology, with an iPad displaying an echocardiogram.
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SmArtphoneS, SmArt heArt
One of these studies, led by Brian Choi, M.D., assistant 
professor of Medicine in the Division of Cardiology, recently 
confirmed that echocardiogram images taken with mobile 
cardiac ultrasound devices are as readable and accurate on 
smartphones and tablet computers as they are on a conven-
tional workstation. These findings mean expert echocardiog-
raphers can receive, review, and interpret high-quality images 
transmitted directly from the field using handheld ultrasound 
devices, making critical diagnoses more accessible and patient 
care more efficient. 
The study began in August 2010, when Cindy Tracy, M.D., 
professor of Medicine and director of Cardiac Services at GW 
Hospital, led a medical mission to Honduras in a particularly 
inaccessible mountainous region of Central America. Because 
of the remote location and a limited ability to bring diagnostic 
equipment, Choi suggested the team use a handheld ultra-
sound device called a GE Vscan. 
“The GE Vscan was perfect for this kind of application 
because it’s so portable,” Choi recalls. The Cheney Cardiovas-
cular Institute took Choi’s advice and purchased the device for 
the trip, allowing Tracy’s team to collect diagnostic images. 
“I was interested in looking at those images to determine if 
reading them off of a smartphone was as accurate as reading 
them on a traditional workstation.”
Working with third-party commercial software developer 
mVisum, which created the HIPAA-compliant smartphone 
application, Choi sent echocardiographs from 89 patients for 
analysis by two experts in the United States, who reviewed 
them on conventional workstations. Afterward, the images 
were also sent to echocardiographers who reviewed them 
using a smartphone. Choi then compared the results. The 
smartphone diagnosis was considered accurate only if an 
abnormal finding matched at the same level of severity as the 
interpretation made using the conventional workstation.
“The correlation between the two was very high,” says 
Choi. “We did a statistical test that showed the diagnoses 
matched 90 percent of the time. Now that we know reading 
echoes from a smartphone is nearly as accurate as reading 
them from a workstation, the key is figuring out how to best 
incorporate this technology into a standard of care.” 
The devices’ implications for medical missions to under-
served locations are clear, but, Choi argues, there are prac-
tical applications for the United States as well. “Not only can 
there be a similar interaction between rural sites and tertiary 
referral care centers,” he says, “but also, these devices could 
fill an important gap in urgent and off-hours interpretations 
when experts may not be immediately available.” 
mediCAtion AdherenCe: phoning it in
GW physicians are also exploring how cell phones might 
improve medication adherence among patients with hyperten-
sion, a disease estimated to affect more than 65 million adults 
in the United States. Following prescriptions is particularly 
important for blood pressure patients because poor adherence 
to medications can result in serious complications, such as 
kidney disease. What’s more, many patients who suffer from 
high blood pressure also have other conditions that could 
result in a drug regimen of up to 10 pills a day.
With a grant from Qualcomm’s Wireless Reach initiative, 
and contributions from One Economy, Cricket Communi-
cations, and VOCEL, GW researchers led a seven-month 
study to determine whether 3G wireless-enabled cell phones 
with a mobile medication reminder application could engage 
patients, improve health outcomes, and reduce health costs. 
They nicknamed the device the Pill Phone.
“High blood pressure and diabetes are the leading causes of 
kidney disease, and Washington, D.C., has some of the highest 
rates of end-stage kidney disease in the nation,” says Richard 
Katz, M.D., Bloedorn Professor of Medicine and director of 
the Division of Cardiology. “The Pill Phone Research Study 
offers a model for disease self-management that can be  
applied to at-risk communities.”
Patients received 3G wireless handsets preloaded with 
the Pill Phone application. They received medication dosage 
reminders, tracked dosage records, images of the pills, and 
real-time information about potential drug side effects and 
interactions. Health care providers were able to remotely 
monitor patient adherence through a secure website.
moBiLe teChnoLogY And mAnAging diABeteS
Meanwhile, two teams of GW researchers are focusing their 
efforts on the impact of mobile technologies on diabetes care 
and management. The teams received grants from the McKesson 
Foundation as part of its Mobilizing for Health initiative, a 
program geared toward improving the health of underserved 
populations through the use of mobile phones. 
One study, led by Joshua Cohen, M.D., professor of Medi-
cine in the Division of Endocrinology, and Neal Sikka, M.D., 
assistant professor of Emergency Medicine, will examine 
the effectiveness of text messaging in reducing emergency 
room (ER) visits by people with diabetes. The team will text 
diabetes information to subjects, who will report on their 
disease management. Via text, subjects will also be able to 
get information about follow-up appointments. The hope is 
that by improving patient education, people with diabetes can 
improve their self-care and help prevent the type of health 
concerns that lead to ER visits. 
The other study, led by co-investigators Samir Patel, M.D., 
associate professor of Medicine in the Division of Renal 
Diseases and Hypertension, and Katz, will be a randomized, 
controlled trial of a cell phone application for patients with 
diabetes and hypertension. Patients will be able to monitor 
their blood glucose and blood pressure, and share that data 
with primary care providers. Researchers aim to create a sus-
tainable care model centered on the cell phone application. n
Practicing Smarter with m-health Technology
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 he question had puzzled doctors for 
more than 100 years: How did nitroglycerin 
— the same explosive compound Alfred 
Nobel famously tamed in his invention 
of dynamite — work as a therapeutic? 
They knew it fl ushed blood into the heart, 
alleviating painful conditions like angina, but 
how? That was the million-dollar question.
For Ferid Murad, M.D., Ph.D., now University 
Professor and professor of Biochemistry and 
Molecular Biology in the GW School of Medicine and 
Health Sciences (SMHS), the answer struck like a lightning 
bolt. He was a young faculty member at the University of 
Virginia (UVA) when he realized nitroglycerin and other blood 
vessel–widening drugs (which he dubbed nitrovasodilators) 
were being converted to nitric oxide (NO) in the body. 
T
    NITRIC OXIDE DISCOVERIES UNRAVEL PATHWAYS 
LEADING FERID MURAD TO THE NOBEL PRIZE — AND Gw
the aNSwer IS
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By Anna Miller | Photography by Michael Leong
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“That was heresy,” says Murad. After all, NO was best 
known as a toxic gas and environmental pollutant — not as 
a molecule with beneficial biological functions. But when 
Murad and his team linked lab-generated NO with a family 
of enzymes called guanylate cyclase (GC), they successfully 
mimicked the lock-and-key combination nitroglycerin uses to 
make blood vessels relax, expand, and encourage blood flow. 
“We did that experiment on Dec. 2, 1976 — I’ll never 
forget it,” he says. “It was one of those ‘eureka’ moments.” 
And it wouldn’t be the last. Two years later, Murad postu-
lated that nitrovasodilators work not by being converted to 
NO in the body, but by prompting smooth muscle cells to 
create the gas themselves. NO, he thought, was behaving as a 
messenger molecule — one uniquely capable of both carrying 
messages between cells (i.e., a first messenger) and entering 
the cells to regulate their functions (i.e., a second messenger). 
And though it took years to prove it, and even longer for the 
scientific community to accept it, Murad was right. 
An inteLLeCtuAL Bridge 
The memory of a molecule once outcast seems distant to 
Murad now — 35 years since the discovery of NO’s first 
biological effects and 13 since he and two colleagues won 
the Nobel Prize in Physiology or Medicine for it. Today, the 
study of NO is one of the most popular in biology, generating 
about 130,000 academic papers each year. Murad estimates 
the molecule has influenced breakthroughs in cardiovascular 
disease, cancer, and arthritis, and — Murad proudly reports 
— formed the basis for Viagra. “It’s just remarkable what it 
can do,” he says. “If you were asked: Does it do this? Does it 
do that? Chances are, the answer is ‘yes.’ ” 
The same could be said of Murad, who has served as 
chief of Medicine at Palo Alto Veterans Hospital, chair of 
Medicine at Stanford University, and most recently director 
emeritus of the Institute of Molecular Medicine at the Univer-
sity of Texas Health Science Center at Houston. He’s founded 
several biotechnology companies, served as an advisor to 
city and government leaders on technology development, and 
lectured around the world. In June, he became the namesake 
of a hospital in Macedonia — the same hospital where his 
Albanian father sold candy as a teenager. 
Through it all, Murad’s philosophy has remained the 
same. “I like to chase problems,” he says. “You have to do 
whatever it takes to answer the most important questions.” 
Most recently, “whatever it takes” comes in the form 
of GW, where, as University Professor — the institution’s 
highest academic title — Murad teaches an undergraduate 
course, mentors medical and postdoctoral students, and leads 
a lab program in SMHS’s Department of Biochemistry and 
Molecular Biology, where he is a full professor. “Something 
significant is happening at GW, and it’s fun to be a part of 
it,” he says. 
And according to University and SMHS leadership, 
Murad’s not just a part of it — he’s driving it. “Dr. Murad’s 
presence on our faculty immediately catalyzes and elevates 
our strategic efforts in advancing scientific discovery, edu-
cating the next generation of physicians and scientists, and 
improving the health and lives of the people we treat,” says 
Jeff Akman, M.D. ’81, G.M.E. ’85, interim vice provost for 
Health Affairs and dean of SMHS. “In many ways, he is an 
intellectual bridge between the University and SMHS.” 
Rakesh Kumar, Ph.D., professor and Catharine Birch & 
William McCormick Endowed Chair of the Department of 
Biochemistry and Molecular Biology, and long-term collabo-
rator of Murad’s, agrees. “Dr. Murad is a compassionate 
colleague and mentor whose infectious intellectual curiosity 
is sparking a fresh spirit of creativity on our campus.”
one pervASive pAthwAY, three importAnt projeCtS
When Murad joined the GW faculty in April, he unpacked 
three nagging questions: Can deadly tumors be treated with 
minimal side effects? How can stem cells be manipulated to 
grow into certain tissue types? Is there a cheap and portable 
way to save the millions of lives lost each year to diarrhea? 
While ostensibly quite distinct, each project stems from the 
cellular signaling pathway that begins with NO and ends 
with cyclic guanosine monophosphate (cGMP), a second mes-
senger that is released inside a cell after GC is activated by 
NO (i.e., the lock and key). 
“NO and cGMP reprogram genes that influence the dif-
ferentiation and proliferation of cells,” explains Murad of 
project number one. “Because some of these effects are related 
to cancer proliferation, interrupting that process can be a 
novel way to treat cancers.” It’s a thought that’s been sim-
mering in Murad’s mind since the 1970s, when his work with 
liver and renal tumor models first indicated a relationship 
between cGMP and tumor proliferation. After several years 
exploring this relationship — and even demonstrating that 
cGMP excretion in the urine of rats correlated with the size of 
their tumors — Murad and his colleagues tabled the project 
because their ambitions exceeded the day’s technologies. 
In recent years, Murad has returned to the pursuit, this 
time focusing on glioblastoma, a “very aggressive, nasty” 
type of brain cancer that Murad estimates kills up to 80 per-
cent of its victims in less than three years. His goal, in broad 
terms, is to enhance the expression of a certain subtype, or 
isoform, of the receptor GC and its product cGMP so that 
the message “grow” cannot be received by the tumor cells. 
So far, Murad and his team of investigators have successfully 
quadrupled the life span of mice injected with manipulated 
tumor cells. “Can we do that with humans? I don’t know, but 
I hope so,” he says. 
Murad’s second project, regenerative therapy, goes hand in 
hand with his first. Like cancer cells, embryonic stem cells are 
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proliferating and differentiating systems whose growth and 
change is dependent upon the messages they receive. If Murad 
can understand whether and how much NO and cGMP 
dictate the messages that tell embryonic stem cells what kind 
of tissue to become, he might also be able to swoop in and tell 
them to be something else. 
So far, Murad and his colleagues have coaxed cell lines 
toward futures as hearts and brains. But, of course, cGMP 
and NO are only part of the story, Murad cautions. “It’s 
going to be a complicated cocktail of goodies you put in your 
cultures to become this or that, and I think part of the story 
will be cGMP or NO.” 
In 20 or 30 years, he predicts, the “organ transplant 
program won’t be necessary anymore. Wouldn’t that be 
wonderful?” 
The third research goal also dates back to the 1970s, 
when Murad helped a colleague at UVA reveal that a bacte-
rial toxin in Bangladesh was causing diarrhea by increasing 
cGMP production, similar to how cholera causes diarrhea by 
increasing the production of another second messenger, cyclic 
adenosine monophosphate (cAMP). The pair demonstrated 
that the only isoform of GC found in the intestinal mucosa, 
particulate GC, is the receptor for the bacteria’s heat-stable 
strain. When that strain interacts with the particulate GC, 
the lock-and-key match unleashes cGMP and prompts diar-
rhea — an illness responsible for the death of about 2 million 
children worldwide each year. 
Ever since, Murad has been on the hunt for the perfect 
compound that plugs the lock between the toxin and the par-
ticulate GC receptor. He and colleagues have already found 
one particularly promising molecule that works with both the 
bacterial toxin and the cholera toxin. And while there is still 
“homework to do” on the compound, including clinical trials 
for toxicity, Murad is optimistic that a marketable therapeutic 
will be developed in his lifetime. “If we can make an impact 
on cancer, if we can make an impact on stem cells, and if we 
can figure out a way to treat infectious diarrhea in third-world 
countries, I will turn up my toes and feel blessed,” he says. 
A prodigY of nAture And nurture
Even as a “youngster,” Murad knew he would go to medical 
school. He had always been smart — remaining at the top of 
his class from grade school through high school, despite rarely 
doing homework — but his desire for higher education was as 
attributable to nurture as it was to nature, he says. Raised in a 
small town in Indiana, Murad learned the value of hard work 
and education from his restaurant-owner parents, neither of 
whom had completed elementary school. “I knew that when 
I grew up, I wanted to accomplish more than my parents,” he 
recalls. The other important component of success, says Mu-
rad, “is identifying that teacher or professor who will get you 
excited about something, guide you, and keep you going.” 
For him, there were many — high school teachers who 
were regulars at his parents’ restaurant, professors during 
his undergraduate years at DePauw University, doctors in 
residency at Massachusetts General Hospital, and scientists 
at his fellowship at the National Institutes of Health. But it 
was while achieving one of the nation’s first dual M.D./Ph.D. 
degrees at Case Western Reserve University that Murad met 
his two most influential mentors: Earl Sutherland Jr., M.D., 
chair of the Department of Pharmacology, and Theodore 
Rall, M.D., a young faculty member in the same lab. 
Murad joined their lab shortly after it had discovered 
cAMP as the first intercellular second messenger — a finding 
for which Sutherland later won a Nobel Prize. “What a won-
derful and exciting time … watching a new area of biology 
develop and actively participating in the work,” writes Murad 
on the Nobel Foundation website. He has studied cellular 
signaling ever since. 
Murad has also embraced the opposite side of the mentor-
ship dyad, training about 150 medical students and fellows 
in his lab over the course of his career. Many have become 
department chairs, several are company presidents, and one is 
the president of a Japanese university, but none have won the 
Nobel Prize … yet. “One of my students has to win the prize 
because I don’t want this lineage in cellular communication 
disrupted in any way,” says Murad, half-joking and alluding 
to the three-generation trend that began with Sutherland’s 
mentor, Carl Corey, who won the prize in 1947 for describing 
how the body uses glycogen for energy. “One of my goals is 
to identify that next generation here at GW.” But even more 
than the Nobel trait, Murad hopes he can pass down his 
passion for research and penchant for problem solving. After 
all, if conducting one revolutionary experiment was his only 
goal, Murad could have stopped that winter night in 1976. 
But “quitting while you’re ahead” is an idea that’s never made 
much sense to Murad. “I hope I never retire,” he says. “I really 
love what I do — solving problems. How long I can go, I don’t 
know. But I am willing to find out.” n
When Murad joined the GW faculty  
in April, he unpacked three nagging  
questions: Can deadly tumors be treated  
with minimal side effects? How can  
stem cells be manipulated to grow into  
certain tissue types? Is there a cheap  
and portable way to save the millions  
of lives lost each year to diarrhea? 
16    GWUMC.EDU    •    F A L L  2 0 1 1
Deconstructing a 
Complex Disorder
A GW researcher applies order and simplification as  
a new step toward understanding autism  
“Order and simplification are the first steps 
toward the mastery of a subject.”
  — Thomas Mann
By Peter Sergo  |  Illustration by Dan Winters  |  Photography by Holger Thoss
On a Wednesday last April, Valerie Hu, Ph.D., professor 
of Biochemistry and Molecular Biology at GW’s School of 
Medicine and Health Sciences (SMHS), eagerly anticipated 
the release of an autism spectrum disorder (ASD) study that 
she authored and that appeared in the online science journal 
PLoS One. The study added to an already large body of 
literature linking specific genes to autism, but Hu emphasized 
that her genome-wide analysis provided “a new twist.” 
Hu’s approach addressed the immense variability of 
autism, a disorder that affects one out of 110 American 
children, according to the Centers for Disease Control and 
Prevention. Autism’s severity and symptoms vary drastically: 
They include language deficiency, repetitive behaviors, 
and restricted social interest; some individuals also exhibit 
epilepsy, sleep disturbance, weak muscle tone, and immune 
system dysfunction. “When I talk to parents about studying 
autism,” Hu says, “I tell them it’s like digging your hand into 
a bowl of mixed fruit and picking out one specific thing.” 
Experts agree that autism is a multi-gene disorder, and 
each gene inflicts a small effect that is compounded by 
environmental factors. The unique jumble of symptoms 
emerges in almost a case-by-case basis. “This heterogeneity in 
symptoms, severity, etc., is the major problem,” Hu explains. 
“Most scientists and geneticists recognize this, but little 
has been done to tease the heterogeneity apart. The result is 
increased ‘noise’ in the biological or genetic data.” 
the BreAkdown
Hu’s recent study seeks to squelch that noise and gain a 
clearer signal by systematically grouping individuals with 
autism into subgroups according to similarity of severity 
scores from the Autism Diagnostic Interview–Revised 
(ADI-R), a behavioral diagnostic assessment. These scores, 
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along with the corresponding individual’s genetic data, were 
obtained from a large study led by faculty at the Children’s 
Hospital of Philadelphia.
Hu clustered nearly 3,000 individuals into four 
distinguishable ASD groups that ranged in severity from mild 
to severely language impaired, with the hope of determining 
whether the behavioral subtypes could be associated with 
different genetic variations. 
This study identified 18 novel genetic variants or single 
nucleotide polymorphisms (SNPs) that were associated 
with one or more subgroups of autism. Interestingly, 
the SNPs were in regions of DNA that didn’t code for 
proteins, suggesting that they may instead regulate gene 
expression. The value of dividing individuals into subgroups 
for the genetic analyses was underscored by the fact that 
no significant SNPs were identified when the cases were 
combined into a single group (Hu’s “bowl of mixed fruit”). 
“To associate genotype with behavioral phenotype is what 
you want for diagnostics,” Hu says. “You want to pick out 
not just risk for autism, but also risk for a type of autism.”
Anthony-Samuel LaMantia, Ph.D., professor of 
Pharmacology and Physiology and director of GW’s new 
Institute for Neuroscience, stresses the importance of taking 
into account autism’s variability when connecting observable 
deficits to their underlying genome. “It’s not as simple as 
making a clinical diagnosis of autism and then finding 
a gene,” he says. “There’s a necessity in identifying each 
behavioral realm and associating it with a number of genomic 
changes. These sorts of groupings will help with that.”
pAtternS emerge
The success of this genome-wide genetic analysis in 
identifying subtype-dependent SNPs supports this subtyping 
strategy, which Hu and her colleagues had previously applied 
to genome-wide gene expression analyses. In a 2009 study 
that analyzed more than 40,000 RNA transcripts per sample, 
both overlapping and unique genes were revealed among 
three of the subtypes examined. 
Among the genes shared between the severe and mild 
subtypes were those linked to cell death, inflammation, 
embryonic development, memory, learning, and muscle tone. 
Unique to the more severe ASD group were genes associated 
with responses to painful and normal stimuli, muscle rigidity, 
epilepsy, and circadian rhythm. 
Altogether, Hu views her findings as necessary steps 
toward targeted therapies in autism. “In order to develop 
a personalized medicine approach to treating a complex 
disorder,” she says, “you need to define what the defect is.”
it’S perSonAL
With good reason, Hu decided in 2004 to pivot her research 
acumen toward autism. “I have a son who’s affected. 
That’s my driving motivation,” she explains. As a parent 
and a scientist, she is all too aware of how the diagnosis of 
autism relies solely on behavioral assessments, since reliable 
biomarkers have yet to become a reality. “Even though 
autism is said to be highly heritable, there’s still no genetic 
or molecular marker,” she says. “So one of the goals of our 
study was biomarker identification.”
With regard to the diagnostic landscape of autism, 
Rakesh Kumar, Ph.D., professor and the Catharine Birch & 
William McCormick Endowed Chair of the Department of 
Biochemistry and Molecular Biology at SMHS, couldn’t agree 
more about the need for a quantitative tool. “There is no 
yardstick to measure autism against,” he says. “There is a lot 
of subjectivity that comes with complex disorders, and they 
cannot be assigned to one single gene product. This is where 
Dr. Hu’s work will be able to fill in the niche.”
Absent a biological understanding of autism, treatment 
options are limited and vulnerable to conjecture. “Right now 
they’re just throwing all these different psychotropic drugs 
at autistic kids,” Hu observes. “My son has been prescribed 
more than 20 different drugs. None of the drugs have 
worked, and many have had intolerable side effects, so now 
he’s not on anything.”
Ideally, making a diagnosis based on peripheral 
biomarkers stems from an understanding of how the detected 
changes relate to the nervous system, LaMantia points out. 
“The diagnostic strategy requires asking whether peripheral 
change in a non-neuronal cell type represents something 
significant in the nervous system,” he adds. 
A frAmework for the Big piCture
Making sense of autism means unraveling its many causes and 
seeing how they relate. Hu likes to construe it as a multilevel 
pyramid with the base representing the observable symptoms, 
or phenotype. The next level is the gene expression profile, 
above which is the genetic hardware that you’re born with 
as well as the ways in which that hardware is interpreted, or 
epigenetics. At the top are the environmental and biological 
triggers, such as hormones and toxins. “Even though autism is 
highly genetic,” Hu notes, “the question is what environmental 
factors impact the genes. That’s the big picture.”
Because genetically identical twins who differ in their 
diagnosis for autism show different gene expression profiles, 
Hu thought it was a good idea to look at DNA methylation, 
an epigenetic process whereby methyl groups attach to DNA 
to dampen gene expression. 
In a 2010 study, Hu and Anh Thu Nguyen, then a 
graduate student working in Hu’s lab, identified the retinoic 
acid-related orphan receptor alpha gene, or RORA, as 
a gene that’s altered by methylation in samples from 
autistic individuals. RORA mutation has been linked to 
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an abnormal cerebellum (the region of the brain that’s 
responsible for coordination and muscle tone) and 
deficiency in a type of neuronal cell (Purkinje), which has 
been the earliest and most consistent brain abnormality 
observed in autism. 
This February, Hu and her collaborators — Tewarit 
Sarachana, a GW Institute for Biomedical Sciences Ph.D. 
candidate, Minyi Xu, a master’s degree student in Biochem-
istry who now serves as a research assistant under Hu; and 
Ray-Chang Wu, Ph.D., assistant professor of Biochemistry 
and Molecular Biology — reported that RORA is regulated 
in opposite directions by male and female sex hormones 
(male hormones repress it), and also that RORA regu-
lates aromatase, an enzyme that converts testosterone to 
estrogen. The study further showed that both RORA and 
aromatase levels are reduced in the brain tissues of autistic 
individuals, thus linking observations initially made with 
non-neuronal tissues to changes in the brain. These findings 
are significant because they provide an explanation for the 
higher amount of testosterone often seen in children with 
autism, which some researchers blame for the 4:1 sex differ-
ence between boys and girls with the disorder. 
“I think females are more protected because estrogen 
can not only elevate RORA expression, but also compen-
sate for a deficiency in RORA by activating the estrogen 
receptor which controls some of the same genes that are 
regulated by RORA,” Hu says. “That’s what I think is 
the beauty of the work with sex hormones. It really helps 
explain the higher levels of testosterone, as well as the sex 
bias in autism.”
eYeS on the prize, feet on the ground
Hu explains her work like a driven detective searching for 
clues. Kumar describes her as a principal investigator who 
single-handedly put GW on the map for autism research. “Her 
work,” he says, “will collectively help to further refine the 
autistic diagnostic kit based on objective, quantitative tests.” 
Hu hopes her work will one day spur better diagnosis 
and treatment of autism. “Sometimes when you think too far 
ahead, it’s so complex,” she reflects. “You wonder whether 
you’ll get to a point where you can really help.” 
LaMantia agrees that solving the riddle of autism will be a 
piecemeal, formidable challenge. “Autism research is moving 
forward right now,” LaMantia observes, “but it is going to be 
complicated, and it will move forward ever so slowly.”
It’s understandable that parents of autistic children would 
find such an outlook sobering. After Hu spoke about autism 
at a recent conference in Utah, a parent asked if giving 
estrogen to her affected son would alleviate symptoms. As a 
parent and a scientific expert, Hu could relate to the eager-
ness. But she framed her answer pragmatically: “You have to 
let research sort that out.” 
Taped to Hu’s computer monitor is a fortune cookie mes-
sage: “Your present plans are going to succeed.” It’s a sage 
reminder for any investigator who has a hunch he or she is 
on the right track. n
“ Even though autism is said to be highly heritable, there’s still no genetic or 
molecular marker, so one of the goals of our study was biomarker identification.”
Valerie Hu, Ph.D.
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The concept of “flow” is a defining characteristic for Ramesh Mazhari. As an 
interventional cardiologist, she is dedicated to restoring and improving patient 
blood flow to the heart. As a researcher, she has transitioned almost effortlessly 
from one new idea to the next. And, with guidance from mentors along the 
way, Mazhari hopes to make it possible for basic science discoveries to move 
swiftly from concept to patient care. h  In the clinic that treats vessel block-
ages, Mazhari, M.D., G.M.E. ’02, G.M.E. ’05, assistant professor of Medicine 
in the Division of Cardiology at GW’s School of Medicine and Health Sciences 
(SMHS), has earned a reputation as an expert in the use of transradial catheter-
ization on patients who experience a blockage of blood flow to their hearts. In 
the laboratory, pursuing stem cell research to restore heart muscle function, she 
is exploring the molecular level of information flow. She is trying to determine 
the pathways that prompt the body to cue — or crush — the cell growth needed 
to repair a damaged heart. She hopes one day to harness that signaling system 
to devise regenerative cardiac treatments. And as a master’s degree student in 
SMHS’s first class of translational medicine specialists, Mazhari is moving to 
the next big paradigm in medicine.
 Principle
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Practice
Cardiac Interventionalist Ramesh Mazhari, 
M.D., G.M.E. ’02, G.M.E. ’05, prepares to 
insert a catheter into the radial artery of a 
patient.
By Anne Brataas  |  Photography by Holger Thoss 
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inSight And ACtion
Mazhari, who completed her residency in internal medicine 
at GW in 2002 as well as a fellowship in cardiac intervention 
at GW in 2005, returned to SMHS three years later as a 
member of the Cardiac Catheterization Laboratory at GW 
Hospital. With encouragement from her mentor, and now 
colleague, Jonathan Reiner, M.D., professor of Medicine 
and director of GW’s catheterization lab, Mazhari pursued 
training in transradial access. The specialized cardiac 
catheterization procedure offers safer access to the heart 
through the radial artery in the patient’s wrist rather than 
taking the traditional approach through the femoral artery. 
The procedure was developed about 20 years ago in 
Europe. Although only about 5 percent of cases in the United 
States use transradial access, it is now the preferred method 
in more than 50 percent of cases in Europe, Canada, and 
Japan. The U.S. standard relies on the larger, straighter 
femoral artery in the groin as a route to the heart. Both 
approaches enable physicians to diagnose coronary blockages, 
and, where possible, restore blood flow by threading a stent 
through the catheter to prop open the vessel. The femoral 
procedure, however, presents bleeding risks and significantly 
greater discomfort for the patient due to the artery’s location 
deep within the thigh muscle. Transradial access is ostensibly 
more difficult because the radial artery is smaller than the 
femoral artery, and the route to the heart is less direct (the 
physician has to guide the catheter up through the patient’s 
arm around the shoulder to reach the heart). Nonetheless, the 
procedure is safer because it reduces the risk of bleeding, and 
it provides a faster recovery time; patients sometimes go home 
on the same day as the procedure.
As is typical of Mazhari’s style, action followed the 
insights she gained from her catheterization training. “After 
three or four cases, I was convinced that transradial access 
“Ramesh is someone 
I trained, but she has 
changed my practice and 
influenced a generation 
of our fellows at GW.”
— Jonathan Reiner, M.D., 
director of GW’s 
catheterization lab
was the better procedure for a cardiac intervention because 
it’s better for the patient,” she says. 
Mazhari suggested to Reiner that GW expand its use 
of transradial access, and after some careful evaluation he 
adopted his protégé’s enthusiasm for the technique. The 
results were so positive that radial access soon became the 
lab’s preferred approach. 
“It’s a much more patient-centered approach,” says 
Reiner. “While the procedure often takes several months 
for physicians to really learn, once they have the expertise, 
they can perform it just as quickly, more safely, and less 
expensively compared with the more common procedure of 
going through the femoral artery.” 
Most catheterization labs in the United States opt for the 
femoral procedure as a first option and switch to the radial 
artery only if there is potential for complications with the 
traditional approach, according to Reiner. GW turned that 
scenario on its head. “Today at GW Hospital, we perform 
almost 90 percent of catheterizations through the wrist,” he 
says. “The procedural outcomes are equivalent, and patients 
prefer it.”
Reiner beams with added satisfaction that the switch to 
transradial access was born of homegrown talent. “Ramesh is 
someone I trained,” recalls Reiner, “but she has changed my 
practice and influenced a generation of our fellows at GW.”
As a result of the transition, GW has become a wellspring 
for training in the transradial technique. “Our fellows come 
out of their years with us having performed hundreds of 
cases, and they really become experts at it,” says Reiner. 
Through its fellowship programs, GW provides specialized 
training in transradial access for two interventionalists and 
eight general cardiology fellows annually. In addition, three 
or four established physicians travel to GW each month to 
learn the technique.
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Connect. Flow. Transform. It’s an algorithm for speeding 
the current of innovation to patients. Mazhari attributes her 
inspiration in exploring new channels of care to the many 
influential mentors who have guided her along her relatively 
young career as a physician. 
“A great mentor is not just a doctor who teaches you 
how to perform a procedure the way he or she does, or how 
to understand a condition based only on their own experi-
ence,” Mazhari explains. “A great mentor teaches you to be 
imaginative, to think differently, and to continue to learn as 
much as you can.” 
of pig LABS And prACtiCe ChAnge
Mazhari’s drive for “different and better” was instilled 
early in her medical career during a fellowship at Boston’s 
Brigham and Women’s Hospital. Developing a research 
project taught her the fine-grained details of how to build 
an operational foundation for research, including managing 
stakeholder input, policy implications, grant requirements, 
and reporting mandates. Right away Mazhari knew she 
wanted a career in both research and patient care. At the 
time, however, translational medicine — quickly moving 
advances in research from the bench to better clinical care 
at the bedside — was only beginning to take shape at a few 
academic medical centers. 
Again, mentoring made the difference for Mazhari. 
Working on another fellowship under Joshua Hare, M.D., 
who was a pioneer in the use of stem cells for repairing dam-
aged heart muscle and was then at Johns Hopkins University, 
Mazhari realized that her dual expertise in research and 
patient care was clinically relevant. During the year-long 
fellowship, she found herself in the lab as a basic science 
researcher investigating stem cells and their impact on the 
heart physiology of pigs. Pigs are routinely used in cardiac 
research because their heart anatomy is similar in size, 
structure, and function to that of humans. Mazhari’s task 
during the project served as a counterpoint to her current role 
as an interventional cardiologist. “Instead of clearing vessels 
to restore blood flow, I was trying to close vessels to induce a 
heart attack in the pigs,” she explains. “Then we would inject 
cardiac stem cells to see if there was any therapeutic effect on 
the heart. In doing a little bit of everything — basic science 
research and clinical care — I really found my calling.” 
CreAtive CoLLABorAtionS
Mazhari kept seeking a link between science and patient 
care. Upon her return to GW in 2008, she found a fertile 
environment in which to integrate her understanding of clini-
cal care and her interest in hard science. The combination 
of freedom and direction offered by mentors such as Reiner, 
Timothy McCaffrey, Ph.D., professor of Biochemistry and 
Molecular Biology, and Eric Hoffman, Ph.D., professor of 
Pediatrics at GW’s SMHS and Children’s National Medical 
Center, enabled Mazhari to reach beyond convention.
This spring she joined one of the nation’s few translational 
medicine degree programs — and the only one in the Wash-
ington, D.C., area. Mazhari is among GW’s inaugural class 
of 15 M.D.s and Ph.D.s training to bridge gaps in care and 
build new platforms for improved health by quickly trans-
lating advances in basic science into new clinical treatments 
for patients. The degree program is part of a partnership 
between GW and Children’s National Medical Center thanks 
to a National Institutes of Health grant — the prestigious 
Clinical and Translational Science Award.
Joseph Bocchino, Ed.D., M.B.A., assistant professor and 
chair of SMHS’s Department of Clinical Research and Lead-
ership, directs GW’s new degree program. He believes trans-
lational medicine exerts new demands on leaders to evolve 
beyond the rapidly declining model of care marked by the 
heroic surgeon, the lone genius in the lab, the solo clinician.
“This emerging domain is all about a social-networking 
approach to problem solving,” Bocchino explains. “It’s done 
largely through multidisciplinary teams, not isolated or loosely 
affiliated individuals. So the process requires a new leadership 
style. Defining and developing this new leadership style is one 
of the essential educational pieces of our program.” 
He adds that traditional research programs train people in 
a deep, but narrow, scope of interest. “In this new program, 
the strategy is to help people develop a broader base of expe-
rience across the continuum, from basic science, to clinical 
research, to matters of health policy.” 
Mazhari explains, “I was attracted to the opportunity to 
enter GW’s translational medicine degree because I had first-
hand experience both in basic heart research and in applying 
new knowledge to patient care.” 
mAking the ConneCtion to Better CAre
Translational medicine is changing how scientific research 
is conducted and health care is delivered in the U.S. because 
it’s helping to overcome medicine’s past problems: A system 
fragmented between basic laboratory research, clinical care 
of patients, and policy support for best-practice methods and 
therapies. 
“In health care right now, there is a huge gap between 
what we know and what we deliver,” says Mazhari. “My 
job as a clinician going through this program is to connect 
those two worlds through translational research. My goal 
is to take the rapidly growing basic science research, and 
use those techniques to try to answer very relevant clinical 
questions. It’s exciting to have this opportunity because in 
medicine, there’s so much more we can do for patients when 
we can make this connection.”
Connect. Flow. Transform. n
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Prescriptions for Sanctuary  
 for refugeeS, MedicAl eVAluAtionS by gw cliniciAnS cAn MeAn tHe difference between life And deAtH 
lot of things seem to walk away from Katalin 
Roth’s office, which, she admits, is “due for a 
clean.” But a simple greeting card isn’t one of 
them. She locates it swiftly, plucks it off the 
bulletin board, and reads it aloud. 
“Thank you very much for everything you have done,” it 
says. “You saved my life. As a Burmese, I worship you every 
day for saving my life.” 
“Isn’t that amazing?” Roth marvels. “It’s the most 
amazing card I’ve ever received.” 
Roth, M.D., J.D., is the division director of Geriatrics 
and Palliative Medicine at the GW Medical Faculty Associ-
ates and an associate professor in the Department of Internal 
Medicine at the GW School of Medicine and Health Sciences 
(SMHS). As a doctor, she is in the business of saving lives. As 
a volunteer medical evaluator of asylum seekers, she helps ref-
ugees like the card’s author — a journalist who fled a country 
where her profession is a crime — create new lives. Her two 
roles are not that different. After all, as Roth wrote in a paper 
published in the Journal of Pain and Symptom Management, 
“helping a refugee achieve legal status in this free country is 
really to save a life.” 
the meAning of ASYLum
The word “asylum” literally means “sanctuary.” Legally, it 
is the right to remain in the United States despite an expired 
visa or illegal entry, and the ability to eventually apply for 
U.S. citizenship. Symbolically, it means freedom. No matter 
how it’s spelled, achieving asylum isn’t easy. 
To earn it, asylum seekers (also called asylees) must prove 
refugee status — they must show that past persecution or a 
well-founded fear of future persecution prevents them from 
returning to their home countries, and that such persecution 
is based on race, religion, nationality, political opinion, or 
membership in a particular social group. Because asylees often 
lack documentation, testimony from a medical evaluator like 
Roth can be the difference between life and death. 
Roth conducts her evaluations at Washington, D.C.’s 
Bread for the City, a nonprofit clinic that provides adminis-
A
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trative support for volunteer physicians, among other services 
to the community. She takes a medical history, conducts a 
physical examination, and asks a lot of questions — about 
the abuse, the escape, detention conditions, and methods of 
torture. She asks about life “before,” and life “after.” 
The most important part of Roth’s job is the listening. It’s 
also the hardest.
Stories of rape, beatings, starvation, and burning; tales of 
amputated fingers, crushed legs, stretched arms, and sliced 
skin fill her asylum interviews. She has documented genital 
mutilation, chronic fungal skin infections, and severe arthritis. 
Though not all scars are visible, the stories are chilling. 
They are acts of torture not accidents. They are deliberate and 
cruel, and, perhaps worst of all, they represent only a fraction 
of the tortures inflicted daily in more than half the world’s 
countries. Those who make it to Roth are the lucky ones. 
“You learn a lot about how terrible people can be to one 
another,” says Roth, who has examined people from the 
Ukraine, Georgia, Pakistan, Ethiopia, Albania, Sudan,  
Guatemala, and more. While in the clinic, she remains sym-
pathetic but detached. “Later, in the privacy of my home,” 
she confesses, “I have shed tears.” 
But her tears are fleeting. The people are inspiring, inter-
esting, and often very brave, she says. “They have the courage 
of their political convictions and stand up to governments.” 
A phYSiCiAn AdvoCAte
Roth’s first patient came to her by way of her colleague Julia 
Frank, M.D., professor of Psychiatry and Behavioral Sci-
ence in SMHS, who had been performing psychiatric evalu-
ations of asylum seekers for about five years. Annie was a 
“thin, frightened young woman” from Cameroon who had 
been arrested and abused in prison presumably because her 
boyfriend was a political activist. With the help of Frank and 
Roth’s documentation, Annie was eventually granted asylum 
and is now a home health aide, a wife, and a mother. 
“While working with Annie, I discovered a new dimen-
sion of myself as a physician,” says Roth. “I had been a 
physician-advocate before … but in this work, I could help 
individuals address international injustice.” 
Roth also shares a personal connection with the refugees. 
Despite having survived persecution as Jews during World 
War II, Roth’s family fled Hungary when she was three 
months old because her father, a small business owner, was a 
capitalist in a communist regime. 
“I grew up hearing the stories of our escape, about the 
bullets whizzing by as the truck driver drove through a 
checkpoint, and the fellow passenger who was killed in the 
escape,” Roth recalls. “So I know firsthand … that immigra-
tion is a choice one makes when one has no other choices.” 
we don’t ASk 
Roth’s experiences with refugees are valuable in the clinic, 
where she argues that doctors know too little about their 
patients. “We don’t ask the veterans what happened in the 
war, whether it’s World War II, Korea, or Vietnam. We don’t 
ask foreign-born patients what kind of turmoil they went 
through. And so we miss out on knowing our patients.” 
Physicians also risk missed diagnoses, she says. Depres-
sion, stomachaches, headaches, and eczema can all be related 
to past traumatic experiences. 
What’s more, “medical care itself can be traumatic to 
people who have been traumatized,” according to Frank. 
Clinic rooms can mirror prison cells, clinicians’ questions can 
echo interrogations, and medical tools can resemble instru-
ments of torture. 
It’s an idea illustrated by one of Roth’s patients, a 70-year-
old Vietnamese-American man named Nguyen who was 
crying as he recovered from lung surgery. He told Roth he was 
not in pain — as long as he remained still. And yet, lying still 
was almost worse: The position reminded him of the torture 
he had endured as an anticommunist in South Vietnam, where 
he was confined to a cage, unable to stand for six months. 
“Nguyen helped me understand how helplessness can be 
re-created in the medical setting and how easily long-buried 
memories of torture can be reawakened in illness,” says Roth.
Back in her office, before reading the greeting card, Roth 
received a phone call about a patient in her geriatric clinic who 
died. She empathized with the caller, admiring the deceased 
and wishing the family her best. With the click of the phone 
and a mark on her chart, another patient was lost forever. 
As a physician, Roth is also in the business of watching 
lives pass. 
“It’s sort of an antidote, I guess,” she says as she pins the 
card back on the bulletin board. In Roth’s world, for each life 
lost, another is saved. n
Katalin Roth, M.D., J.D.
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As he anticipated the final out in the World Series last No-
vember, Ken Akizuki, M.D. ’93, ran from the San Francisco 
Giants’ clubhouse to the end of a tunnel behind the team’s 
dugout. When the Giants won, the team’s orthopedic sur-
geon followed the hugging, screaming, jumping players onto 
the field to celebrate. 
The next day, Akizuki rode in the team’s victory parade 
through downtown San Francisco. A sea of confetti coated 
a roaring sidewalk crowd estimated at more than 1 million. 
Later, the Giants awarded Akizuki the same World Series 
ring the players and coaches received. 
“I wear the ring every day,” Akizuki says. “And every day 
my patients want to wear it and take a picture with it. I think 
they are more interested in my ring than they are in me.” 
Celebrating the World Series championship with the team and 
owning a World Series ring are just two among many fantasy 
“perks” Akizuki receives as the Giants’ orthopedic surgeon. 
He doesn’t have to search to uncover the path that led 
him to this moment. For Akizuki, it began during his final 
year as a student at GW’s School of Medicine and Health 
Sciences (SMHS), as he prepared to pick a residency. 
“It was tough to choose a specialty, because as a student 
you wanted to emulate the professors you liked and looked 
up to,” recalls Akizuki. “But the seed to go into orthopedics 
was probably implanted in my fourth year of medical school. 
My GW professors helped me get a great residency in general 
surgery at Los Angeles County Harbor–UCLA Medical 
Center, and when I went into the residency I felt that my 
education was as good as what was provided by any medical 
school in the country.”
Orthopedic Surgeon Ken Akizuki, M.D. ’93, keeps the San Francisco Giants standing tall.
ALumNus ProFiLE
There When Giants Fall
  orthopedic Surgeon ken Akizuki, m.d. ’93, works to keep major Leaguers  
on their feet and rounding  the Bases
By Gary Libman
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He adds, “I can’t tell you how many other professors 
and people touched my life. My classmates and faculty were 
tremendous. The impact of the mentors and other people I 
met was invaluable. I was helped a great deal by a couple 
of orthopedic residents: Ken Yamaguchi, now the Sam and 
Marilyn Fox Distinguished Professor of Orthopedic Surgery 
at Washington University School of Medicine in St. Louis, 
and Ammar Bafi, who was the chief resident in General 
Surgery and is now a cardiovascular surgeon at Washington 
Hospital Center.”
In his role with the Giants, Akizuki works at nearly all of 
the team’s 81 home games and spends another three weeks 
with the team during spring training. That’s in addition to 
his full-time practice. 
Akizuki works the games not just because he’s been a 
Giants fan since childhood, and not just because in the club-
house he regularly encounters Major League Baseball royalty, 
such as former Giant Willie Mays or such current players as 
two-time Cy Young Award winner Tim Lincecum. He’s at 
the clubhouse because he feels responsible to the players. 
“Baseball’s a funny game,” says Akizuki, 45. “The 
majority of injuries are a result of repetitive stress, and the 
more you are around, the more you get to see the evolution 
of injury and you get to know the athlete and they get to 
see you. The more you’re around and the better the players 
know you, the more they trust you.”
Akizuki starts each season with the Giants in late February 
at spring training in Scottsdale, Ariz. He and other team doc-
tors provide physicals for the Giants’ 180 to 200 major and 
minor league players and treat frequent pre-season injuries. 
When the season begins in early April, he frequently 
works 15-hour days. On nights when the Giants play at 
home, he sees private patients from 7:30 a.m. to 5:30 p.m. 
and plants himself in the Giants’ locker room from 6 p.m. to 
11 p.m.
When he arrives at the locker room, “There’s usually a 
list of players I need to see, and I prioritize those,” he says. 
“Some may be playing that night. I’ll usually meet with 
the player and training staff and make decisions. Often the 
player will have taken batting and infield practice. After-
ward, we’ll assess how they’re doing. It’s a long season and a 
grind. The players are always banged up a little, some more 
than others, and you’ve got to make decisions on a day-to-
day basis.
“I try to multitask, doing paperwork from my practice 
during the game,” Akizuki continues. “I’m pretty intent on 
watching the game on a monitor in the clubhouse. A lot of 
players who are preparing to play in the later innings leave 
the dugout and come into the clubhouse. They have their 
rituals to get ready; like relief pitchers who come in and get 
stretched out. Guys who’ve been injured for a long time come 
in to rehab, and I talk to them. We watch the game together.”
He adds, “The hardest thing about the job is that the 
training staff and I have to make a lot of tough decisions in 
terms of injuries. People always want to know how quickly 
we can get these guys back on the field; our job is to do so 
safely and do it right.”
Among those Akizuki has successfully treated were two 
players struck in the head at separate times by a batted ball, 
one on the mound and the other in the dugout. But common 
complaints, especially among pitchers, include labral tears, 
impingements, tendinitis in the shoulder, and ulna collateral 
ligament problems in the elbow. 
As a pitcher–infielder at Branham High School in San 
Jose, Akizuki personally avoided these injuries. Unfortu-
nately, he adds, the injuries, once confined to professionals, 
are becoming more common among amateur athletes. 
“The most concerning thing I see,” he says, “especially 
in youth baseball, is that kids are getting the same injuries 
in the shoulders and elbows at a much younger age. At 37, 
a guy has had a major league career. But at age 12, the con-
cern is that if you’re getting an operation on your shoulder 
or elbow, how long will the player last? Will they last 
through high school or college or even professional baseball 
if that’s their goal?” 
Akizuki ’s grateful that the medical school stressed the 
importance of treating not just the injury but the whole 
person. “You are taught the physiology and the anatomy,” he 
says, “but you’re also taught to always remember that you’re 
dealing with a human being.” 
After applying what he learned during his residency at Los 
Angeles County Harbor–UCLA Medical Center, Akizuki was 
immediately invited in 2000 to join the Giants medical team. 
He became the team’s orthopedic surgeon in 2004.
As he’s working in the locker room, he frequently 
sees Mays and other noted former Giants, such as Willie 
McCovey and Orlando Cepeda, but it’s the current staff who 
receive the bulk of his attentions.
“I try not to get involved in players’ lives,” Akizuki says. “I 
need to be their doctor and maintain objectivity and distance. 
Inside me, it’s like a dream. This is the team you rooted for as 
a kid. I want to be a fan and root for them. But you can’t act 
like a fan. You’ve got to be professional.” n
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Fertile Research
Medical Resident JennifeR aMbRoggio looks foR 
new Methods foR identifying the best eMbRyos 
to ensuRe successful iMplantation 
A decade ago, Jennifer Ambroggio, M.D., was a seasoned 
embryologist living in California with her husband and 
young child. But something wasn’t quite right. “I felt isolated 
in the lab,” she remembers. “It was my relationship with 
the patients who benefited from my work that was the most 
fulfilling.” So Ambroggio and her family packed their bags 
and moved east, so she could attend medical school.
Now, Ambroggio, a resident at GW’s School of Medicine 
and Health Sciences (SMHS), is glad she made the move — 
and GW is glad too, presenting her with the 2011 Clinical 
Research Award during this year’s Research Day for a study 
that could influence future assisted reproductive technology 
(ART) procedures.
Patients undergoing ART procedures, such as in vitro 
fertilization (IVF) or fertility drug treatment, are more likely 
to have multiple-birth pregnancies than women who conceive 
naturally. Although just 1 percent of the infants born in the 
United States were conceived through some form of ART 
in 2006, according to CDC reports, 
they account for almost 20 percent of 
multiple births nationwide. For many 
women, multiple-birth pregnancies 
are not just undesirable — they are 
dangerous, posing a higher risk of 
complications, including preterm births 
and low birth weight. 
Ambroggio’s study, called “Multi-
nucleation of a Sibling Blastomere 
on Day 2 Suggests Unsuitability 
for Embryo Transfer in In Vitro 
Fertilization — Preimplantation 
Genetic Screening Cycles,” explores 
new methods of predicting which 
embryos are healthiest and best suited 
for implantation, a technique that could 
lead to both an increased likelihood 
of a successful pregnancy following 
IVF and a reduction in the number of 
multiple-birth pregnancies. The study 
was published in the American Society 
for Reproductive Medicine journal Fertility and Sterility (v. 
94, n. 4, p. S127). 
Ambroggio and researchers at the GW IVF Center 
analyzed cells from 1,189 three-day-old embryos to test for 
aneuploidy — genetic damage resulting in any number of 
chromosomes other than the normal 23. Their data showed 
that embryos containing multinucleated blastomeres, even 
when found to be normal following preimplantation genetic 
diagnosis, did not result in any successful pregnancies.
Blastomeres are the cells that make up an embryo 
during its first few days of development. During normal 
meiosis, each cell nucleus must replicate itself. When the 
cell divides, sometimes the nucleus will double itself but 
the cytoplasm won’t divide, resulting in a multi-nucleated 
blastomere. “Not every embryo, even one created in vivo, is 
genetically normal,” says Ambroggio. Those with inherent 
genetic abnormalities are more prone to multinucleation, she 
explains. 
Ambroggio concluded that given the choice, physicians 
should pick an embryo without multi-nucleated blastomeres. 
“Or, if you have a lot of embryos to choose from and you are 
undergoing preimplantation genetic testing,” she adds, “you 
can forgo biopsying those embryos with multi-nucleated 
blastomeres, because you can be pretty certain that they’re 
not going to lead to a pregnancy. This would save money for 
patients, and help them achieve better outcomes.”
—Thomas Kohout
Medical Resident Jennifer Ambroggio, M.D.
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Akman Tapped by Mayor  
to Serve on D.C. HIV/AIDS 
Commission
Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, interim 
vice provost for health affairs and dean of GW’s 
School of Medicine and Health Sciences, was 
appointed by Washington, D.C., Mayor Vincent 
Gray to serve on the newly established Com-
mission on HIV/AIDS. Akman is recognized as 
an expert in the psychiatric care of gay, lesbian, 
bisexual, and transgender individuals (GLBT).
“Mayor Gray’s decision to establish this com-
mission reflects a significant commitment by the 
city to intensify its efforts to address the HIV/
AIDS epidemic that is affecting so many people 
in the nation’s capital,” Akman said.
With an HIV/AIDS prevalence of more than 
3 percent among its adult population, Wash-
ington, D.C., suffers from the highest infection 
rate of any city in the United States and a rate 
more than three times above the threshold for 
what the Centers for Disease Control and Pre-
vention considers a “severe epidemic.” 
Akman is one of a handful of psychiatrists 
who defined and developed the field of HIV/
AIDS psychiatry in the mid-1980s. He was the 
principal investigator of a National Institutes of 
Health grant to train health care professionals 
in medical and mental health aspects of HIV/
AIDS, and has presented at numerous national 
meetings on the subjects of HIV/AIDS neuropsy-
chiatry and GLBT psychiatry. n
Signing on with  
the Senior Society
GW’s School of Medicine and Health Sciences 
(SMHS) Senior Alumni, Faculty, and Emeriti So-
ciety recently welcomed Edward De Fabo, Ph.D., 
research professor of Microbiology, Immunolo-
gy, and Tropical Medicine; Willis A. McGill, M.D., 
professor of Anesthesiology and Critical Care 
Medicine and of Pediatrics; Frances Noonan, 
M.D., professor of Microbiology, Immunology, 
and Tropical Medicine; Stephen Rosenblum, 
Brem Welcomed as Fellow in the 
American College of Radiology 
Rachel F. Brem, M.D., F.A.C.R., director of Breast Imaging and In-
tervention, and vice chair, Department of Radiology at GW’s School 
of Medicine and Health Sciences, was welcomed as a Fellow in the 
American College of Radiology (ACR) during the association’s 88th 
ACR Annual Meeting and Chapter Leadership conference.   
Brem is among the just 10 percent of ACR members who achieve 
this high honor, which is awarded to clinicians with a history of ser-
vice to the ACR, as well as achievement in Radiology, teaching, or 
research. n
M.D., clinical professor of Psychiatry and Behavioral Sciences; and 
Melvin Stern, M.D., clinical professor of Psychiatry and Behavioral 
Sciences, into its select association. All five new members are also in 
the 2011 class of GW emeriti faculty.  
The Senior Society, chaired by Seymour Perlin, M.D., professor 
emeritus of Psychiatry and Behavioral Sciences; Constance Battle, 
M.D. ’67, adjunct professor of Prevention and Community Health; and 
Stanley Marinoff, M.D., professor emeritus of Obstetrics and Gyne-
cology, promotes continued intellectual, creative, and social engage-
ment for GW medical emeriti, retiring/retired faculty, and local alumni 
from SMHS who graduated in the 1970s or earlier. 
Launched in the spring of 2010 with the motto, “You can’t retire from 
what you are,” the society hosts a series of events that foster and pre-
serve relationships among physicians, scientists, and scholars who are 
transitioning into retirement from their faculty positions or local prac-
tices, but who wish to remain productive in their discipline. n
Rachel F. Brem, M.D., F.A.C.R.
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Griffith Receives 
Award for  
Contributions to  
Psychiatry and Culture
James L. Griffith, M.D., professor of 
Neurology, interim chair of Psychiatry 
and Behavioral Science, and director 
of the Psychiatry Residency Program 
at GW’s School of Medicine and 
Health Sciences (SMHS), received the 
Creative Scholarship Award from the  
Society for the Study of Psychiatry 
and Culture (SSPC) at its annual 
meeting, June 2–4. The award is 
given annually to an individual who 
has made a recent, significant, and 
creative contribution to the field of 
cultural psychiatry.
“Learning how to treat patients 
within the family, community, and 
cultural contexts of their lives is still 
a frontier for American psychiatry. I 
am honored to be given the Creative 
Scholarship Award for my efforts,” 
said Griffith, who developed a model 
of psychiatric residency training that 
focuses on both culture and neurosci-
ence to prepare residents for practice 
in the multiethnic and international 
communities of Washington, D.C. 
Two SMHS Psychiatry residents 
were also recognized during the 
SSPC meeting. Yavar Moghimi, M.D., 
a fourth-year resident and recipient 
of the 2010 John Spiegel Fellowship, 
presented a documentary about how 
long-term inmates in the Washing-
ton, D.C., prison system adjust to life 
outside prison following their release. 
Brandon Kohrt, M.D., a third-year resi-
dent, received the 2011 John Spiegel 
Fellowship for his work with the Carter 
Center to improve mental health care 
in Liberia. n
The Developing Brain 
and Cancer
Just a few decades ago, the connec-
tion between neurobiology and cancer 
biology was suspected, but unspoken.
“Today it is one of the most robust 
interfaces between basic neurosci-
ence and clinical medicine,” said 
Anthony-Samuel LaMantia, Ph.D., 
professor of Pharmacology and Physi-
ology in GW’s School of Medicine and 
Health Sciences (SMHS) and founding 
director of the GW Institute for Neuro-
science at the first annual Neurosci-
ence symposium, April 27.
The symposium, titled, “The Devel-
oping Brain and Cancer,” featured 
four leading researchers — including 
SMHS’s Sally Moody, Ph.D., professor 
of Anatomy and Regenerative Biology, 
and Vittorio Gallo, Ph.D., professor of 
Neuroscience at SMHS and director 
and Wolf-Pack Chair in Neurosci-
ence at the Center for Neuroscience 
Research at Children’s National Med-
ical Center. They highlighted advances 
in neuroscience that contribute to the 
understanding of the developing brain 
and how cancer can compromise it. 
Moody detailed the earliest stages 
of nervous system development, and 
Gallo discussed how certain signaling 
pathways help maintain the balance 
between specific, critical types of 
neurons developed in the brain. 
After presentations by graduate 
SMHS students, the GW Cancer Insti-
tute hosted a panel discussion about 
the future of neuroscience research 
moderated by the institute’s Executive 
Director Steven Patierno, Ph.D. n
Cawley Receives  
Eugene A. Stead 
Award of Achievement 
The American Academy of Physician 
Assistants (AAPA) selected James 
Cawley, P.A.-C., M.P.H, professor of 
Physician Assistant Studies in GW’s 
School of Medicine and Health Sci-
ences (SMHS), to receive the Eugene 
A. Stead Award of Achievement for his 
pivotal role in moving the Physician 
Assistant (P.A.) profession forward 
through his work as a certified practi-
tioner, educator, scholar, and leader. 
Cawley is founder and director of 
GW’s joint P.A./M.P.H. program, the 
first of its type in the United States, 
which trains individuals for careers 
that bridge clinical practice and dis-
ease prevention. n 
Wasserman Elected to 
AOA Board
Alan G. Wasserman, M.D., Eugene 
Meyer Professor, and chair, Department 
of Medicine and President, GW Medical 
Faculty Associates, has been elected 
to the board of directors of Alpha 
Omega Alpha as a councilor director. 
The board consists of members of the 
society elected by the board of direc-
tors based on recommendations from 
the nominating committee and installed 
after election by the board.
Wasserman previously served as 
an Alpha Omega Alpha councilor, 
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helping to nominate local members, contribute to service 
projects, and administer chapter activities. As a councilor 
director, he will maintain his responsibilities as a councilor, 
as well as assist in the decision-making process that will 
lay the foundation for the future of the society. n
Look Before You Tweet
New research conducted by Katherine Chretien, M.D., 
F.A.C.P., associate professor of Medicine at GW’s School of 
Medicine and Health Sciences, reveals that although social 
media has a potential positive role in medicine, greater 
accountability and clear guidelines are needed, as some 
physicians who are regular users of Twitter are disseminat-
ing unethical and unprofessional content. A research letter 
titled, “Physicians on Twitter,” was included in the Feb. 9 
edition of the Journal of the American Medical Association.
“This research helped us to identify how physicians are 
using social media and has helped us gauge whether or 
not there is need for greater accountability for physicians 
who use social media,” said Chretien. “While the majority 
of tweets were potentially helpful, the ethical breaches and 
unprofessional content raised a red flag.”
The study, approved by the Washington, D.C., Veterans 
Administration Medical Center, was initiated to review the 
professionalism of self-identified physicians on Twitter 
and how they use the social media tool. Over a one-month 
span Chretien examined 5,156 tweets from 260 physicians 
with 500 or more followers. She found that 3 percent of the 
tweets could be categorized as “unprofessional,” meaning 
that they included profanity, potential patient privacy 
violations, sexually explicit material, or discriminatory 
statements. n
Newman Named CEO  
of Children’s National
Kurt Newman, professor of Surgery, and of Pediatrics, at 
GW’s School of Medicine and Health Sciences, was named 
president and chief executive officer for Children’s National 
Medical Center effective Sept. 1, 2011. Newman has been 
at Children’s National for more than 25 years and most 
recently served as the senior vice president of the Joseph 
E. Robert Jr., Center for Surgical Care.
“Dr. Newman articulated an impressive vision to lead 
Children’s National,” said James Lintott, chair of the Board 
of Directors at Children’s National Medical Center. “He 
is an accomplished physician, researcher, educator, and 
administrator and is poised to lead an already vibrant team 
dedicated to caring for kids.”  
A board committee launched a national search following 
the retirement announcement by Edwin K. Zechman, after 
17 years of leadership. n
Margaret Plack, P.T., Ed.D., Receives 
American Physical Therapy  
Association’s Award
Margaret Plack, P.T., Ed.D., interim senior associate dean 
for the Health Sciences Programs and associate professor 
of Health Care Sciences at GW’s School of Medicine and 
Health Sciences (SMHS), received the Award for Leader-
ship in Education from the American Physical Therapy 
Association (APTA). This award, which is the highest honor 
conferred by the education section of APTA, is given to 
individuals who have had a substantial impact on physical 
therapy and physical therapy education through scholar-
ship, teaching, administration, and service activities.
“There are few people in the country who have accom-
plished as much as Dr. Plack to advance our under-
standing of the importance of physical therapy and how it 
can help improve the lives of patients, especially children,” 
says Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, interim vice 
provost for Health Affairs and dean of SMHS.
Plack received her award during the education section 
business meeting and reception at the combined sections 
meeting of the APTA in February. n
Margaret Plack, P.T., Ed.D. 
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Savvy Support from  
Evelyn Y. Davis
The business-savvy side of Evelyn Y. Davis appreciates that 
her physicians at The George Washington University Medical 
Faculty Associates (MFA) work together to keep her healthy. 
In order to show them just how much she appreciates them, 
she and the Evelyn Y. Davis Foundation recently established 
the Evelyn Y. Davis Fund with a gift of $100,000 to support 
several MFA clinical departments. 
Davis, who studied Business Administration at GW, con-
siders herself the nation’s foremost activist-shareholder. She 
owns stock in roughly 80 corporations and has been a vocal 
participant at shareholder meetings across the country since 
the 1960s. She is the founder and editor of Highlights and 
Lowlights, a national financial newsletter featuring analysis 
on key business issues such as corporate governance and exec-
utive compensation, which is distributed only to the CEOs of 
national corporations. Davis is a regular guest on financial 
news programs such as CNBC, Fox Business News, and 
Comcast Newsmakers, and is frequently featured in many 
national newspapers. She also has been an invited lecturer 
at many universities and colleges, including Babson College, 
Northwestern University’s Medill School of Journalism, the 
Darden School of Business at the University of Virginia, and 
Penn State’s School of Journalism.
Born in Amsterdam, the Netherlands (which, she jokes, 
was “on the wrong side of the ocean, but the very right side of 
the tracks”), Davis was a member of GW’s Class of 1951, the 
same class as Jacqueline Bouvier Kennedy Onassis, and has 
generously offered support to many areas of the University.
“Evelyn Y. Davis has always been very supportive,” says 
Alan G. Wasserman, Eugene Meyer Professor, and chair 
Department  of Medicine, and president of the MFA. “Thanks 
to her generosity, we will be able to advance our clinical care 
programs and provide service to our patient community.”
Adopt a Doc
new scholaRship pRogRaM enables sMhs aluMni 
to put a face and a naMe to donations 
Allison Hoff had nearly exhausted her five minutes at an 
Internet café when the e-mail arrived. “Congratulations!” 
it read. “Based on your exemplary record, the Committee 
on Admissions is pleased to offer you a School of Medicine 
Scholarship … while in the Doctor of Medicine degree pro-
gram at The George Washington University.” 
“I was shocked,” says Hoff, who was attending a wedding 
in Greece before moving from California to Washington, 
D.C., to begin life as a GW medical student. 
Hoff, a former Peace Corps volunteer, had never even 
heard of — let alone applied for — the scholarship she 
received. No one had. But with that e-mail, Hoff became the 
first “Adopt a Doc” scholar in a new program through which 
School of Medicine and Health Sciences (SMHS) alumni 
can support an incoming medical student’s education with a 
minimum gift of $20,000 over four years. 
To whom did Hoff owe thanks for the generous surprise? 
SMHS alumnus Russell Libby, M.D. ’79, a Virginia pediatri-
cian who developed the fund in memory of his mother, Leona 
Libby Feldman. Libby’s siblings and stepfather, and each of 
their families, have since contributed to the fund. 
“I wanted to create something that embodies who my 
mother was in a concise and meaningful way,” says Libby, 
a longtime donor to SMHS. “I feel good knowing that the 
contribution has a name and a face and is someone for whom 
I can potentially act as a mentor.” 
Hoff and Libby met for the first time on Aug. 10. It was 
the beginning of what is expected to be a special relationship 
for both. “Being a physician has been a huge privilege,” says 
Libby. “I am grateful for my roots at GW, and I feel it is my 
duty to support those who come after me.” n
First-Year medical student Allison Hoff with Russell Libby, M.D. ’79.
Above from left, George Washington University President Steven Knapp, 
Evelyn Y. Davis, and Medical Faculty Associates CEO Stephen Badger.
Continued on page 34
P
h
o
to
g
r
a
P
h
y
 t
o
P
 —
 M
Ic
h
a
e
l 
le
o
n
g
; 
b
o
t
to
M
 —
Je
S
S
Ic
a
 M
c
c
o
n
n
e
ll
 b
u
r
t
 M E D I C I N E  +  H E A LT H        3332   GWUMC.EDU    •    F A L L  2 0 1 1
CLAss NoTEs
1940s
Luther W. Brady, M.d. ’48, 
Distinguished University Professor, 
Department of Radiology Oncology, 
Drexel University College of Medicine, 
recently received the Philadelphia 
County Medical Society’s Cristol Award 
for enhancing the society’s educational, 
scientific, and charitable goals. Brady 
also received the Pennsylvania Medical 
Society’s Distinguished Service Award.
Bernard OstrOW, M.d. ’48, retired 
last year after many years of service 
in the Department of Medicine at 
GW’s School of Medicine and Health 
Sciences.
1960s
FLOyd d. LOOp, M.d. ’62, G.M.e. ’68, joined 
the board of directors for Management 
Health Solutions, Inc. Loop has been 
published more than 350 times and 
has served on the editorial boards of 
numerous health care publications. 
arthur siMinGtOn, M.d. ’68, received 
the Franklin Norwood Rogers Award as 
New Hampshire Retired Pediatrician of 
the Year for 2010. He officially retired 
in 2001, but stayed on as a consultant 
in the developing field of pediatric 
mental health care until 2003.
1970s
richard L. aBBOtt, M.d. ’71, was named 
the new president of the American 
Academy of Ophthalmology on 
Jan. 1, 2011. Abbott was most recently 
a member of the academy’s Committee 
of Secretaries and chair of the board of 
Ophthalmic Mutual Insurance Compa-
ny. He received the academy’s Lifetime 
Achievement Award in 2006, and he 
was elected into the Academia Ophthal-
mologica Internationalis in 2008. 
pauL rOth, M.d. ’76, chancellor of the 
University of New Mexico (UNM) 
Health Sciences Center and dean of the 
UNM School of Medicine, will serve as 
chair-elect for the Greater Albuquer-
que Chamber of Commerce Board of 
Directors. He recently served as acting 
president of UNM while President 
David Schmidly recovered from surgery 
to remove a small tumor.
1980s
MichaeL r. Marks, M.d. ’82, G.M.e. ’87, 
M.B.a., was appointed vice president 
of business development at Norwalk 
Hospital in Connecticut. Marks will 
be responsible for the hospital’s busi-
ness development, occupational health 
services, and marketing and communi-
cations. 
MeLanie BOne, M.d., G.M.e. ’86, received 
the Annual Women in Leadership Award 
presented by the Executive Women of 
the Palm Beaches, on May 2011, for her 
hard work, passion, and success in 
medicine. 
WiLLiaM hiGGins, M.d. ’86, was named 
the Medical Director of the Westchester 
Medical Practice, in Yorktown Heights, 
N.Y., where he will oversee the medical 
operations of the group. 
JeFFrey s. FischGrund, M.d. ’87, was 
named one of the 100 Best Spine Sur-
geons and Specialists in America by 
Becker’s Orthopedic and Spine Re-
view. Fischgrund is a spine surgeon at 
Beaumont Orthopaedic Center in Royal 
Oak, Mich. He is a researcher on bone 
morphogenic proteins and cervical disc 
replacements. Fischgrund has served 
as editor-in-chief of the Journal of the 
American Academy of Orthopaedic 
Surgeons since 2009. 
MichaeL cLyde dOLL, p.a.-c. ’88, was 
recently elected to serve a two-year term 
as director-at-large for the American 
Academy of Physician Assistant’s Board 
stuart s. kassan, M.d. ’72, F.a.c.p., F.a.c.r., was inducted into 
the Alpha Omega Alpha (AOA) Honor Medical Society’s Class 
of 2011 in recognition of his dedication to the profession and 
art of healing. As a member of the University Board of Trustees 
and president of GW’s School of Medicine Alumni Associa-
tion, Kassan was elected to the GW chapter by AOA members 
representing students, faculty, and staff of the GW School of 
Medicine and Health Sciences.
“It’s a tremendous honor to be recognized by peers, and 
even more gratifying when that recognition comes from your 
medical school alma mater,” said Kassan. 
Kassan is an internationally known expert in the treatment 
of Sjogren’s Syndrome, a complex rheumatic disease that typi-
cally affects multiple areas of the body. He has served as a clini-
cal professor of Medicine at the University of Colorado Health 
Sciences Center since 1994. 
Election to Alpha Omega Alpha is a lifelong honor signify-
ing a lasting commitment to scholarship, leadership, profes-
sionalism, and service. 
James Katz, M.D., professor of Medicine; David Diemert, 
M.D., assistant professor of Microbiology, Immunology, and 
Tropical Medicine; David Popiel, M.D., assistant clinical pro-
fessor of Medicine; Howard Pryor, M.D., Surgery; and Jean-
nie Yu, M.D., assistant clinical professor of Medicine; were 
also elected to GW’s AOA Class of 2010–11. Edward O’Neil 
Jr., M.D. ’87, was elected as an alumnus member; and Peter 
Moskovitz, M.D., clinical professor of Orthopaedic Surgery, 
received the Volunteer Clinical Faculty Award.
continued on page 35
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ClaSS NoteS ClaSS NoteS 
founding dean
haL B. JensOn, M.d. ’79, was se-
lected from a pool of more than 60 
applicants to become the found-
ing dean of the Western Michi-
gan University (WMU) School of 
Medicine in spring 2011. Jenson 
most recently served as a professor 
of pediatrics and regional dean in 
Springfield, Mass., at the Western 
Campus of the Tufts University 
School of Medicine in Boston. He 
brings more than 30 years of expe-
rience as a physician and educator 
to his new position. 
“Dr. Jenson is the right choice to 
lead the development of our medi-
cal school,” said WMU President 
John M. Dunn. “He brings a strong 
background in academic medicine, 
medical education, and research.”
Residential Support
A home can offer shelter, safety, and a sense of belonging, but what if it could also 
provide a path to self-discovery, or academic achievement, or advancements in 
research? A generous gift from a former medical resident promises to help GW’s 
School of Medicine and Health Sciences do just that by training future generations 
of mental health professionals and helping them cope with the rigors of their pro-
fession. And it’s all thanks to a home.
Cynthia B. Stevens, M.D., G.M.E. ’89, and her husband, Charles W. Havens 
IV, have created a fund to support psychotherapy and psychoanalytic training for 
psychiatry residents at GW. Established through a bequest stemming from the sale 
of their home in Lander, Wyo., the endowed fund will enable the Department of 
Psychiatry and Behavioral Sciences to continue to attract skilled residents. The 
fund will provide financial assistance to residents for personal psychotherapy — a 
key component of comprehensive training in psychotherapy and a cornerstone of 
psychoanalytic training. 
Stevens, a board-certified psychiatrist and psychoanalyst, served as the chief 
resident for outpatient services during her training at GW. Her clinical expertise 
and interest lie with personality development, life change issues and stressors, and 
anxiety and depressive disorders. She has been nationally recognized for her out-
standing contributions to medical student and resident education. n
philanthropy, continued from page 32
Creating a Meaningful Legacy
at GW is
66 As I enjoy retirement, I continue
to reflect on GW-the place where it
all started . Through my estate planning,
I'm doing my part to ensure that the
dream I lived can be realized by others
in the future. 1) 
- George Ellis, MD 156
'r. Ellis is supporting the GW Medical Center with a gift of
$100,000 through his IRA. His estate will receive a significant
tax deduction and GW will receive the designated portion of
his IRA tax-free.
If you have a retirement plan, it's easy to help
deserving students receive a world-class education
in the nation's capital. You can name the GW School
of Medicine and Health Sciences, Public Health and
Health Services , or Nursing as a beneficiary of some or
all of the funds that may remain in your IRA, 401(k),
or other plan after your lifetime. Just complete a new
beneficiary designation form that includes the Medical
Center and its Tax ID number (53-0196584) and
submit it to your plan administrator.
A few of the benefits:
No change in lifestyle since your gift comes from
leftover funds.
Elimination of income and estate taxes that
otherwise would be due.
Flexibility to support the program of your choice.
We can answer your questions to help make it even
easier . Contact us today!
CALL: 202-994-7657
EMAIL: plannedgivingl @gwu.edu
ONLINE: www.gwu.edu/give/plannedgiving
I 
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suMMeR of seRVice
Jack suMMer, G.M.e. ’81, received the Jane Lingo Alumni Outstanding Service 
Award this spring in recognition of his long-standing commitment to educating 
and mentoring GW medical students as well as providing desperately needed ba-
sic medical care for some of the world’s most underserved communities.
Summer leads teams of doctors as well as GW medical and public health stu-
dents on a medical mission each spring to Thomonde, in Haiti’s impoverished 
Central Plateau. The trips, in cooperation with the nonprofit organization Project 
Medishare, offer students the opportunity to learn firsthand about the health 
problems that plague Haiti, as they help provide basic health care to as many as 
200 patients daily in health centers and mobile clinics, treating patients for both 
acute and chronic diseases.
Summer completed his internship and residency training in Internal Medicine 
at SMHS in 1981. He was a member of the GW Medical Faculty Associates, and 
served as associate chair for clinical affairs in the Department of Health Care 
Sciences until 1991. Summer currently practices in Washington, D.C., and also 
serves as assistant clinical professor of Medicine at GW.  
The Jane Lingo Alumni Outstanding Service Award was created in honor of 
Jane Lingo, B.A. ’46, a dedicated alumna, staff member, and friend of GW. The 
award is presented annually to faculty or staff members who are also George 
Washington University alumni.
ClaSS NoteS 
continued from page 33
Baltimore, Md., and will specialize in 
pancreatic and liver surgery. His recently 
published bilingual book of children’s 
poetry, Dinosaur Name Poems, was se-
lected as winner of the 2009 Moonbeam 
Children’s Book Award. 
Lt. cMdr. peter seBeny, M.d. ’03, M.p.h. 
’97, deputy head, clinical trials and 
military studies, and research physician 
in the United States Navy at the U.S. 
Naval Medical Research Unit No. 3 in 
Cairo, was awarded the medal “Knight 
of National Order of June 27th” by 
Djibouti Prime Minister His Excellency 
Dileita Mohamed Dileita, for his efforts 
in supporting capacity-building projects 
with the Djibouti Ministry of Health.
JOhn yarBrOuGh, M.d. ’04, M.B.a., 
recently joined the medical staff at St. 
Joseph’s Behavioral Health Center in 
Stockton, Calif. He is a member of the 
American Academy of Psychiatry and 
Law, the American Academy of Child 
and Adolescent Psychiatry, and the 
American Psychiatric Association, and 
Vice President of the Christian Medical 
and Dental Association — Psychiatry 
Section. 
continued on page 36
of Directors. Doll is a clinically practic-
ing physician assistant at the Geisinger 
Medical Center in Danville, Penn. 
1990s
k. danieL rieW, M.d., G.M.e. ’94, was 
named one of the 100 Best Spine Sur-
geons and Specialists in America by 
Becker’s Orthopedic and Spine Re-
view. Riew is the chief of Washington 
University School of Medicine’s surgical 
spine center and director of the univer-
sity’s Cervical Spine Institute. Among 
his clinical and research interests, Riew 
leads a group of experts at Washington 
University treating the spinal injuries 
of retired National Football League 
players.
sOFia teFeri, M.d. ’97, F.a.a.p., has been 
selected to participate in the 2010–11 
class of the Claude Moore Physician 
Leadership Institute, where she will 
strengthen her leadership abilities and 
gain the skills necessary to improve 
health care in Virginia. 
2000s
steven cunninGhaM, M.d. ’01, has 
joined the staff at St. Agnes Hospital in 
In Memoriam
Alumni
Bernard Katzen, a.a. ’34, M.d. 
’38, the first of six family members 
to attend GW and the first of four 
Katzens to earn a degree from its 
School of Medicine and Health Sci-
ences (SMHS), passed away on Aug. 3, 
2011.
Katzen served in World War II 
and was a member of the invasion 
forces that landed on Normandy 
Beach June 6, 1944, according to 
his Washington Post obituary. After 
the war, he opened a family practice, 
which he maintained for 49 years. 
The Katzen family is deeply inter-
twined with the success of The GW 
Cancer Institute (GWCI). Katzen, his 
wife Mildred, A.A. ’45, B.A. ’46, his 
late brother Cyrus, and his sister-in-
law Myrtle devoted considerable time 
and attention to raising awareness 
and support for GWCI’s mission, 
particularly in the areas of general 
oncology, radiation oncology, and 
clinical care. 
Katzen is survived by his wife; his 
sister, Sally Cohen; his sons, Burton 
and Harvey; three grandchildren; and 
three great-grandchildren. Katzen’s 
son Harvey and grandson Jason are 
SMHS alumni, having earned their 
M.D. degrees in ’75 and ’06, respec-
tively. His nephew —  Jay Katzen, 
B.A. ’67, M.D. ’72 — is a GW 
trustee. 
Leonard C. aKMan, B.a. ’41, 
M.D. ’43, passed away April 2, 2011. 
After receiving his B.A. and M.D. 
from GW, Akman performed his resi-
dency in Internal Medicine at Sinai 
Hospital in Baltimore, Md. In 1946 
he joined the United States Army 
and served as a captain and medical 
officer general, and later served as a 
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In Memoriam
alumni
SeyMour l. AlterMAn, M.d. ’47
Hector l. AlVArez, b.S. ’99
len HugHeS AndruS, M.d. ’44
rodney A. APPell, M.d., g.M.e. ’75
VernA y. bArefoot, M.d. ’50
rolf H. beSSin, M.d. ’64
wAyne bucHAnAn, cert ’95
rAlPH J. cArbo Jr., M.d., g.M.e. ’50
robert J. cereMSAk, M.d. ’60
conStAnce lArk cerny, b.S. ’80
robert n. coAle, M.d. ’43
MAurice c. coVey, M.d. ’56
robert HerMAn crAbtree, M.d. ’54
woodrow f. croSby iii, cert ’03
cleM c. croSSlAnd Jr., M.d. ’46
crAig MicHAel curtiS, cert ’04
SHerMAn dAnielS, M.d., g.M.e. ’87
Andrew P. dedick, M.d. ’43
edwArd A. downS, M.d. ’54
MicHAel edwArd drinkwAter, A.S. ’84
Victor eScH, M.d. ’48
kAng fAn, M.d., g.M.e. ’69
ricHArd lee fArMer, M.S. ’07
donnie d. flint, b.S. ’82
Milton A. foor, M.d. ’52
SAMuel e. friSHMAn, b.S. ’53
MicHAel V. gAllAgHer, cert ’03
cArMen gAnnon, M.d. ’76
PAMelA elizAbetH gelder, b.S. ’95
Joel StePHen glASer, M.d., g.M.e. ’64
JoHn S. gleAton, cert ’04
robert P. HAberkern, M.d., g.M.e. ’70
williAM H. HAll, M.d., g.M.e. ’79
AlAn c. HAMPSHire, M.d. ’59
Percy J. HowArd, M.d. ’53
denniS r. JAckSon, b.S. ’90
dorotHy S. JAeger-lee, M.d. ’39
donAld A. JoHnSon, M.d. ’45
JoHn M. kennelly Jr., M.d. ’48
dAniel l. kirk, M.d. ’43
U.S. merchant marine ship surgeon. 
Following a cardiology fellowship at 
Michael Reese Hospital and Medical 
Center in Chicago, Akman returned 
to Sinai Hospital, rising to the post of 
chief of the Division of Cardiology. 
Akman performed early research in 
heart transplantation and was a pio-
neer in the use of cardiac catheteriza-
tion and cineradiography. Akman was 
a fellow of the American College of 
Physicians, the American Heart As-
sociation, and the American College 
of Cardiology, where he also served as 
a governor. He is survived by a loving 
family, including Jeffrey S. Akman, 
M.D. ’81, interim vice provost for 
Health Affairs and dean of the School 
of Medicine and Health Sciences. 
edward MCFarLand, M.d. ’41, 
longtime friend and supporter of the 
GW School of Medicine and Health 
Sciences, died in March 2010 at the 
age of 94. He served in World War II 
as a flight surgeon and was awarded 
two battle stars. He practiced medi-
cine, obstetrics, and anesthesiology 
from 1946 to 1979.
Faculty
HerBert weintrauB, M.d., 
retired professor emeritus of Anesthe-
siology at GW Hospital, chair of the 
operating room committee, chair of 
the audit committee at the Medical 
Faculty Associates, and chair of the 
Graduate Education Planning Com-
mittee, died Feb. 24, 2011. 
Henry FeFFer, M.d., a GW profes-
sor emeritus and prominent Washing-
ton, D.C., spine surgeon, died May 
9, 2011. Feffer began practicing in 
Washington in the late 1940s, and was 
one of the first white physicians to 
cArl r. lAHti, M.d. ’49
JoHn M. lAnHAM, M.d.’62
grAHAM Seldon leeS, b.S. ’88
williAM w. loebMAn, M.d., g.M.e. ’79
iVAn b. MAHAdy, M.d. ’67
rAlPH A. nernberg, b.S. ’50
frederick c. norcroSS, M.d. ’64
SAMAntHA c. noSek, cert ’04
rAyMond A. nueVe, cert ’00
MelVin orAM, M.d. ’53
SuzAnne M. PittS, M.d. ’60
cHArleS Plotkin, M.d. ’83
MArgAret Ann rAgAn, cert ’96
irVing l. reif, M.d. ’36
guy A. ricHArdS, M.d. ’43
PHylliS A. riggS, b.S. ’84
rAlPH b. roMney, M.d., g.M.e. ’49
MArk H. rozAnS, M.d. ’86
robert gordon ScHAller, A.S. ’77
Victor ScHocken, M.d. ’56
briAn gerArd ScnornAck, cert ’04
Sol SHAz, M.d., g.M.e. ’69
williAM H. SHeffield, M.d. ’61
cAtHerine r. SMitH, M.d. ’41
dAVid f. SMitH, M.d. ’58
eugene o. SteVenSon, M.d. ’60
erin f. StewArt, M.d. ’02
dAniel J. Stone, M.d. ’43
Anne M. tHoMPSon, M.d., g.M.e. ’71
eMMet J. tHorPe, M.d. ’51
Helen r. tHorSen, b.S. ’83
duSAn tiSMA, M.d., g.M.e. ’80
loiS w. turnbAugH, M.d., g.M.e. ’71
ricHArd H. VelAJ, M.d., g.M.e. ’85
continued from page 35 openly treat black patients. Feffer 
chaired the medical advisory com-
mittee for the humanitarian aid 
organization CARE and spent many 
vacations during the 1960s and ’70s 
training doctors in countries such as 
Vietnam, Algeria, and Afghanistan. 
He became an emeritus professor in 
the mid-1980s.
H. George Mandel, Ph.D.  
June 6, 1924 – July 15, 2011
Everybody knew H. George Mandel, Ph.D., a faculty member 
in GW’s School of Medicine and Health Sciences’ (SMHS) 
Department of Pharmacology and Physiology for over 60 
years. “Even when I went to the doctor, the doctor would ask, 
‘How’s George?’” says Stella Moody, manager of departmen-
tal fiscal operations, who worked with Mandel for 17 years.
And, according to Moody, SMHS faculty, staff, and 
students regularly used words such as kind and gentle to 
describe Mandel, demonstrating that he wasn’t only well-
known — he was also well-loved. So it is an understatement 
to say that Mandel, who — as far as records indicate — was 
the longest-serving faculty member in SMHS history, will be 
missed. Mandel passed away July 15, 2011, at age 87.
“It is difficult to exaggerate all that George Mandel did for 
our department and our school,” wrote Vincent Chiappinelli, 
Ph.D., interim associate dean of SMHS, associate vice provost 
for health affairs, and chair of the department, upon hearing 
the news of Mandel’s passing. “He joined GW in 1949 and 
continued to give lectures, run the Caucus of Basic Biomedical 
Science Chairs, and interview prospective students up until 
a few years ago. He was loved by our students, faculty, and 
staff. George was a gentle and sincere man who helped so 
many people. He made a difference and will be missed.”
Mandel joined GW as a research associate and served as 
a faculty member from 1950 to 2010, including 36 years as 
department chair of the Department of Pharmacology prior 
to its merger with Physiology. After stepping down as depart-
ment chair in 1996, he continued to conduct research and 
mentor young faculty members and medical students until 
2010, when he became chair emeritus. In his letter recom-
mending Mandel for emeritus status, Chiappinelli wrote, “Dr. 
Mandel has made huge contributions to our school in many 
areas, including leadership, teaching, research, and service. 
In so many ways [he] exemplifies the ‘long and distinguished 
service to the University’ that is described in the faculty code 
when reviewing faculty members for emeritus status.”
Mandel’s love of teaching students was evident in his 
participation in various activities, including Problem-Based 
Learning, a series of small group conferences in which he dis-
cussed clinical problems with first- and second-year medical 
students. He also organized a pharmacology discussion group 
elective for senior medical students. One of his mentees, Julius 
Axelrod, Ph.D., won the Nobel Prize in Physiology or Medi-
cine in 1970 for work on a class of neurotransmitters.
Equally passionate about research and policy, Mandel 
served as chair of the National Caucus of Basic Biomedical 
Science Chairs from its founding in 1991 until 2008. The 
caucus was a groundbreaking science policy group composed 
of leaders of science associations and chairs of basic science 
departments across the country, which promoted increased 
funding for health research by educating political leaders 
about its importance in improving the health of citizens.   
Mandel received numerous awards throughout his career, 
including the Distinguished Achievement Award from the 
Washington Academy of Sciences in 1958; the Golden Apple 
Teaching Award from the Student American Medical Asso-
ciation in 1969, 1985, and 1997; GW’s George Washington 
Award in 1998; and the 2005 Distinguished Researcher Award 
during GW’s 2005 Research Day. He became a member of the 
Society of Distinguished Teachers at SMHS in 2001.
During World War II, Mandel worked for the U.S. mili-
tary as an interrogator. As a German immigrant and chemist, 
Mandel was recruited to “interrogate scientifically trained and 
experienced German prisoners of war who had been sent to 
this country by the military,” he told NPR in a 2008 interview 
about Fort Hunt, the camp where he worked. All information 
he and his colleagues gained  — which included “discoveries in 
microwaves, atomic and molecular studies, jets used in German 
planes, and submarine technology” — was sent directly to the 
Pentagon, according to a 2008 Washington Post article.
“Dr. Mandel’s contributions to GW and to this nation are 
immeasurable,” said Jeffrey Akman, M.D., interim vice pro-
vost for Health Affairs and dean, SMHS. “He will be greatly 
missed by his colleagues and by the thousands of SMHS 
alumni he taught and mentored.” n
in memorium
H. George Mandel, Ph.D., circa 1966
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Keeping the San Francisco 
Giants Standing Tall
GW’s School of Medicine and Health Sciences 
alumnus Ken Akizuki, M.D. ’93, parlayed a love 
of baseball and a gift for medicine into a ticket 
to the big leagues with the San Francisco Giants 
as the team orthopedic surgeon.
The GeorGe WashinGTon UniversiTy school of Medicine and healTh sciences
A CleAr PAth to 
the heArt 
Cardiac Interventionalist  
Ramesh Mazhari, M.D.
SCHOOL OF ME D I C I N E
AND HEALTH SCIENCES
